967 PRECLINICAL CHARACTERIZATION OF SCH 900518, A NOVEL MECHANISM-BASED INHIBITOR OF HCV NS3 PROTEASE (Englisch)
- Neue Suche nach: Tong, X.
- Neue Suche nach: Arasappan, A.
- Neue Suche nach: Bennett, F.
- Neue Suche nach: Chase, R.
- Neue Suche nach: Feld, B.
- Neue Suche nach: Guo, Z.
- Neue Suche nach: Hart, A.
- Neue Suche nach: Madison, V.
- Neue Suche nach: Malcolm, B.
- Neue Suche nach: Pichardo, J.
- Neue Suche nach: Tong, X.
- Neue Suche nach: Arasappan, A.
- Neue Suche nach: Bennett, F.
- Neue Suche nach: Chase, R.
- Neue Suche nach: Feld, B.
- Neue Suche nach: Guo, Z.
- Neue Suche nach: Hart, A.
- Neue Suche nach: Madison, V.
- Neue Suche nach: Malcolm, B.
- Neue Suche nach: Pichardo, J.
In:
JOURNAL OF HEPATOLOGY
;
50
;
S351
;
2009
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:967 PRECLINICAL CHARACTERIZATION OF SCH 900518, A NOVEL MECHANISM-BASED INHIBITOR OF HCV NS3 PROTEASE
-
Beteiligte:Tong, X. ( Autor:in ) / Arasappan, A. ( Autor:in ) / Bennett, F. ( Autor:in ) / Chase, R. ( Autor:in ) / Feld, B. ( Autor:in ) / Guo, Z. ( Autor:in ) / Hart, A. ( Autor:in ) / Madison, V. ( Autor:in ) / Malcolm, B. ( Autor:in ) / Pichardo, J. ( Autor:in )
-
Erschienen in:JOURNAL OF HEPATOLOGY ; 50 ; S351
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2009
-
Format / Umfang:S351
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.3623
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.3623 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 50
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Liver biopsy: The best, not the gold standardBedossa, P. / Carrat, F. et al. | 2009
- 4
-
Towards the non-invasive diagnosis of cirrhosis: The nuts-cirrhosis connectionBosch, J. et al. | 2009
- 7
-
Settling the "score" with liver cancerKoh, C. / Liang, T. J. et al. | 2009
- 10
-
Hepatocellular cancer care: Cost is important but only one factor of disease burdenKanwal, F. / El-Serag, H. B. et al. | 2009
- 13
-
Are herbals as safe as their advocates believe?Seeff, L. B. et al. | 2009
- 17
-
Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?Bonekamp, S. / Kamel, I. / Solga, S. / Clark, J. et al. | 2009
- 36
-
Exceeding the limits of liver histology markersMehta, S. H. / Lau, B. / Afdhal, N. H. / Thomas, D. L. et al. | 2009
- 42
-
Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistanceDegertekin, B. / Hussain, M. / Tan, J. / Oberhelman, K. / Lok, A. S. et al. | 2009
- 49
-
Clinical relevance of the 2prime-5prime-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis CMihm, U. / Ackermann, O. / Welsch, C. / Herrmann, E. / Hofmann, W. P. / Grigorian, N. / Welker, M. W. / Lengauer, T. / Zeuzem, S. / Sarrazin, C. et al. | 2009
- 59
-
Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scoresCastera, L. / Bail, B. L. / Roudot-Thoraval, F. / Bernard, P. H. / Foucher, J. / Merrouche, W. / Couzigou, P. / de Ledinghen, V. et al. | 2009
- 69
-
Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary stricturesBuis, C. I. / Geuken, E. / Visser, D. S. / Kuipers, F. / Haagsma, E. B. / Verkade, H. J. / Porte, R. J. et al. | 2009
- 80
-
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis BYuen, M. F. / Tanaka, Y. / Fong, D. Y. / Fung, J. / Wong, D. K. / Yuen, J. C. / But, D. Y. / Chan, A. O. / Wong, B. C. / Mizokami, M. et al. | 2009
- 89
-
The burden of illness associated with hepatocellular carcinoma in the United StatesLang, K. / Danchenko, N. / Gondek, K. / Shah, S. / Thompson, D. et al. | 2009
- 100
-
Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinomaYamashita, T. / Honda, M. / Takatori, H. / Nishino, R. / Minato, H. / Takamura, H. / Ohta, T. / Kaneko, S. et al. | 2009
- 111
-
Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilisStickel, F. / Droz, S. / Patsenker, E. / Bogli-Stuber, K. / Aebi, B. / Leib, S. L. et al. | 2009
- 118
-
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic interventionHo, H. K. / Pok, S. / Streit, S. / Ruhe, J. E. / Hart, S. / Lim, K. S. / Loo, H. L. / Aung, M. O. / Lim, S. G. / Ullrich, A. et al. | 2009
- 128
-
Interferon a increases metalloproteinase-13 gene expression through a polyomavirus enhancer activator 3-dependent pathway in hepatic stellate cellsDiaz-Sanjuan, T. / Garcia-Ruiz, I. / Rodriguez-Juan, C. / Munoz-Yague, T. / Solis-Munoz, P. / Solis-Herruzo, J. A. et al. | 2009
- 140
-
Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis CWedemeyer, I. / Bechmann, L. P. / Odenthal, M. / Jochum, C. / Marquitan, G. / Drebber, U. / Gerken, G. / Gieseler, R. K. / Dienes, H. P. / Canbay, A. et al. | 2009
- 150
-
Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitisHenckaerts, L. / Jaspers, M. / Van Steenbergen, W. / Vliegen, L. / Fevery, J. / Nuytten, H. / Roskams, T. / Rutgeerts, P. / Cassiman, J. J. / Vermeire, S. et al. | 2009
- 158
-
High lifetime risk of cancer in primary sclerosing cholangitisClaessen, M. M. / Vleggaar, F. P. / Tytgat, K. M. / Siersema, P. D. / van Buuren, H. R. et al. | 2009
- 165
-
Comparison of blood tests for liver fibrosis specific or not to NAFLDCales, P. / Laine, F. / Boursier, J. / Deugnier, Y. / Moal, V. / Oberti, F. / Hunault, G. / Rousselet, M. C. / Hubert, I. / Laafi, J. et al. | 2009
- 174
-
Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: The HEmochromatosis FAmily StudyJacobs, E. M. / Hendriks, J. C. / van Deursen, C. T. / Kreeftenberg, H. G. / de Vries, R. A. / Marx, J. J. / Stalenhoef, A. F. / Verbeek, A. L. / Swinkels, D. W. et al. | 2009
- 184
-
Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challengesThompson, A. / Patel, K. / Tillman, H. / McHutchison, J. G. et al. | 2009
- 195
-
Primary Budd-Chiari syndromeValla, D. C. et al. | 2009
- 204
-
Epidemiology of non-alcoholic fatty liver disease in ChinaFan, J. G. / Farrell, G. C. et al. | 2009
- 211
-
Test for hepatitis B virus infection with radical immunoassay and real-time PCR: Which method is the gold standard?Xuan, S. Y. / Xin, Y. N. / Zhong, Y. D. / Zheng, M. H. / Guan, H. S. et al. | 2009
- 212
-
What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? Beyond the applause for higher sensitivityHuang, C. I. / Dai, C. Y. / Huang, J. F. / Yu, M. L. et al. | 2009
- 213
-
Reply to comments on "What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?"Togashi, H. / Kawata, S. et al. | 2009
- 214
-
Role of nosocomial hospital transmission in acute hepatitis CMorin, T. / Pariente, A. / Cadranel, J. F. / Denis, J. et al. | 2009
- 214
-
Role of nosocomial hospital transmission in acute hepatitis C: ReplyForns, X. et al. | 2009
- 215
-
Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patientsParini, R. / Furlan, F. / Notarangelo, L. / Spinazzola, A. / Uziel, G. / Strisciuglio, P. / Concolino, D. / Corbetta, C. / Nebbia, G. / Menni, F. et al. | 2009
- 222
-
EWI-2wint - A host cell factor inhibiting hepatitis C virus entrySchuster, C. / Baumert, T. F. et al. | 2009
- 225
-
Announcements| 2009
- 227
-
EASL Clinical Practice Guidelines: Management of chronic hepatitis BEuropean, A. f. et al. | 2009
- 243
-
EASL Clinical Practice GuidelinesPawlotsky, J. M. et al. | 2009
- 244
-
Anti-HCV core antibody: A potential new marker of occult and otherwise serologically silent HCV infectionMichalak, T. I. / Pham, T. N. et al. | 2009
- 247
-
Is family history of liver cancer a risk factor for hepatocellular carcinoma?Volk, M. L. / Lok, A. S. et al. | 2009
- 249
-
Iron in NASH, chronic liver diseases and HCC: How much iron is too much?Pietrangelo, A. et al. | 2009
- 252
-
HBV protein as a double-barrel shot-gun targets epigenetic landscape in liver cancerHerceg, Z. / Paliwal, A. et al. | 2009
- 256
-
Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitopeQuiroga, J. A. / Castillo, I. / Llorente, S. / Bartolome, J. / Barril, G. / Carreno, V. et al. | 2009
- 264
-
Occult hepatitis B virus infection in hepatitis B vaccinated children in TaiwanMu, S. C. / Lin, Y. M. / Jow, G. M. / Chen, B. F. et al. | 2009
- 273
-
The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: A longitudinal analysisFang, Z. L. / Sabin, C. A. / Dong, B. Q. / Wei, S. C. / Chen, Q. Y. / Fang, K. X. / Yang, J. Y. / Wang, X. Y. / Harrison, T. J. et al. | 2009
- 281
-
The role of HBV genotype core promoter and precore mutations in advanced liver disease in renal transplant recipientsTsai, M. C. / Chen, C. H. / Lee, C. M. / Chen, Y. T. / Chien, Y. S. / Hung, C. H. / Wang, J. H. / Lu, S. N. / Yen, Y. H. / Changchien, C. S. et al. | 2009
- 289
-
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapyShouval, D. / Lai, C. L. / Chang, T. T. / Cheinquer, H. / Martin, P. / Carosi, G. / Han, S. / Kaymakoglu, S. / Tamez, R. / Yang, J. et al. | 2009
- 296
-
Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertensionTiani, C. / Garcia-Pras, E. / Mejias, M. / de Gottardi, A. / Berzigotti, A. / Bosch, J. / Fernandez, M. et al. | 2009
- 306
-
Outcome after wait-listing for emergency liver transplantation in acute liver failure: A single centre experienceBernal, W. / Cross, T. J. / Auzinger, G. / Sizer, E. / Heneghan, M. A. / Bowles, M. / Muiesan, P. / Rela, M. / Heaton, N. / Wendon, J. et al. | 2009
- 314
-
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantationVarchetta, S. / Oliviero, B. / Francesca Donato, M. / Agnelli, F. / Rigamonti, C. / Paudice, E. / Arosio, E. / Berra, M. / Rossi, G. / Tinelli, C. et al. | 2009
- 323
-
Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancerChang, Q. / Zhang, Y. / Beezhold, K. J. / Bhatia, D. / Zhao, H. / Chen, J. / Castranova, V. / Shi, X. / Chen, F. et al. | 2009
- 334
-
The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United StatesHassan, M. M. / Spitz, M. R. / Thomas, M. B. / Curley, S. A. / Patt, Y. Z. / Vauthey, J. N. / Glover, K. Y. / Kaseb, A. / Lozano, R. D. / El-Deeb, A. S. et al. | 2009
- 342
-
High-fat nutrition reduces hepatic damage following exposure to bacterial DNA and hemorrhagic shockLuyer, M. D. / Derikx, J. P. / Beyaert, R. / Hadfoune, M. h. / van Kuppevelt, T. H. / Dejong, C. H. / Heineman, E. / Buurman, W. A. / Greve, J. W. et al. | 2009
- 351
-
Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitisSorrentino, P. / D'Angelo, S. / Ferbo, U. / Micheli, P. / Bracigliano, A. / Vecchione, R. et al. | 2009
- 358
-
The role of microRNA expression pattern in human intrahepatic cholangiocarcinomaChen, L. / Yan, H. X. / Yang, W. / Hu, L. / Yu, L. X. / Liu, Q. / Li, L. / Huang, D. D. / Ding, J. / Shen, F. et al. | 2009
- 370
-
A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infectionBerres, M. L. / Papen, S. / Pauels, K. / Schmitz, P. / Zaldivar, M. M. / Hellerbrand, C. / Mueller, T. / Berg, T. / Weiskirchen, R. / Trautwein, C. et al. | 2009
- 377
-
Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3AZheng, D. L. / Zhang, L. / Cheng, N. / Xu, X. / Deng, Q. / Teng, X. M. / Wang, K. S. / Zhang, X. / Huang, J. / Han, Z. G. et al. | 2009
- 388
-
Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patientsWerner, M. / Almer, S. / Prytz, H. / Lindgren, S. / Wallerstedt, S. / Bjornsson, E. / Bergquist, A. / Sandberg-Gertzen, H. / Hultcrantz, R. / Sangfelt, P. et al. | 2009
- 394
-
Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent processGagliardo, B. / Kubat, N. / Faye, A. / Jaouen, M. / Durel, B. / Deschemin, J. C. / Canonne-Hergaux, F. / Sari, M. A. / Vaulont, S. et al. | 2009
- 402
-
Ribavirin: Current role in the optimal clinical management of chronic hepatitis CReddy, K. R. / Nelson, D. R. / Zeuzem, S. et al. | 2009
- 412
-
Treatment failure in hepatitis C: Mechanisms of non-responseTai, A. W. / Chung, R. T. et al. | 2009
- 421
-
HCV and fat: Something is missingGiannini, E. G. / Savarino, V. et al. | 2009
- 422
-
Hepatitis C viremia and serum lipid levels: A clue from an epidemiology studyDai, C. Y. / Chuang, W. L. / Ho, C. K. / Yu, M. L. et al. | 2009
- 423
-
Interpreting liver stiffness in the cirrhotic rangeBioulac-Sage, P. / Couffinhal, T. / Foucher, J. / Balabaud, C. P. et al. | 2009
- 424
-
Interpreting liver stiffness in the cirrhotic range: What are we measuring?Castera, L. / Forns, X. / Alberti, A. et al. | 2009
- 426
-
Acute hepatitis B in a healthcare worker: A case report of genuine vaccination failureBoot, H. J. / van der Waaij, L. A. / Schirm, J. / Kallenberg, C. G. / van Steenbergen, J. / Wolters, B. et al. | 2009
- 432
-
Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIVGozlan, J. / Lacombe, K. / Gault, E. / Raguin, G. / Girard, P. M. et al. | 2009
- 435
-
Chronic hepatitis E in the immunosuppressed: A new source of trouble?Bihl, F. / Negro, F. et al. | 2009
- 438
-
Corrigendum to "Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma" [J Hepatol 49 (2008) 557-563]La Mura, V. / De Renzo, A. / Perna, F. / D'Agostino, D. / Masarone, M. / Romano, M. / Bruno, S. / Torella, R. / Persico, M. et al. | 2009
- 441
-
Regulation of hepatitis C virus replication by microRNAsPietschmann, T. et al. | 2009
- 445
-
Genetic variability of hepatitis B virus and response to antiviral treatments: Searching for a bigger pictureYuen, L. K. / Locarnini, S. A. et al. | 2009
- 449
-
Role of genotyping in Wilson's diseaseSchmidt, H. H. et al. | 2009
- 453
-
Regulation of the hepatitis C virus genome replication by miR-199a*Murakami, Y. / Aly, H. H. / Tajima, A. / Inoue, I. / Shimotohno, K. et al. | 2009
- 461
-
The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypesSvicher, V. / Gori, C. / Trignetti, M. / Visca, M. / Micheli, V. / Bernassola, M. / Salpini, R. / Gubertini, G. / Longo, R. / Niero, F. et al. | 2009
- 471
-
Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis CHuang, J. F. / Dai, C. Y. / Yu, M. L. / Shin, S. J. / Hsieh, M. Y. / Huang, C. F. / Lee, L. P. / Lin, K. D. / Lin, Z. Y. / Chen, S. C. et al. | 2009
- 479
-
Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomesKim, S. I. / Shin, D. / Lee, H. / Ahn, B. Y. / Yoon, Y. / Kim, M. et al. | 2009
- 489
-
Prevention of steatohepatitis by pioglitazone: Implication of adiponectin-dependent inhibition of SREBP-1c and inflammationDa Silva Morais, A. / Lebrun, V. / Abarca-Quinones, J. / Brichard, S. / Hue, L. / Guigas, B. / Viollet, B. / Leclercq, I. A. et al. | 2009
- 501
-
Liver biopsy findings from healthy potential living liver donors: Reasons for disqualification, silent diseases and correlation with liver injury testsMinervini, M. I. / Ruppert, K. / Fontes, P. / Volpes, R. / Vizzini, G. / de Vera, M. E. / Gruttadauria, S. / Miraglia, R. / Pipitone, L. / Marsh, J. W. et al. | 2009
- 511
-
The long-term follow-up after idiosyncratic drug-induced liver injury with jaundiceBjornsson, E. / Davidsdottir, L. et al. | 2009
- 518
-
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinomaLin, Z. Z. / Hsu, H. C. / Hsu, C. H. / Yeh, P. Y. / Huang, C. Y. / Huang, Y. F. / Chen, T. J. / Kuo, S. H. / Hsu, C. / Hu, F. C. et al. | 2009
- 528
-
LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinomaWang, B. / Feng, P. / Xiao, Z. / Ren, E. C. et al. | 2009
- 538
-
Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in ratsKeshavarzian, A. / Farhadi, A. / Forsyth, C. B. / Rangan, J. / Jakate, S. / Shaikh, M. / Banan, A. / Fields, J. Z. et al. | 2009
- 548
-
Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesisJohal, H. / Marie Scott, G. / Jones, R. / Camaris, C. / Riordan, S. / Rawlinson, W. D. et al. | 2009
- 555
-
Genotype-phenotype correlation in Italian children with Wilson's diseaseNicastro, E. / Loudianos, G. / Zancan, L. / D'Antiga, L. / Maggiore, G. / Marcellini, M. / Barbera, C. / Marazzi, M. G. / Francavilla, R. / Pastore, M. et al. | 2009
- 562
-
Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient miceIshii, H. / Horie, Y. / Ohshima, S. / Anezaki, Y. / Kinoshita, N. / Dohmen, T. / Kataoka, E. / Sato, W. / Goto, T. / Sasaki, J. et al. | 2009
- 572
-
The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse modelButura, A. / Nilsson, K. / Morgan, K. / Morgan, T. R. / French, S. W. / Johansson, I. / Schuppe-Koistinen, I. / Ingelman-Sundberg, M. et al. | 2009
- 584
-
Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: An open label trialSharma, P. / Kumar, A. / Sharma, B. C. / Sarin, S. K. et al. | 2009
- 592
-
Alteration of protein glycosylation in liver diseasesBlomme, B. / Van Steenkiste, C. / Callewaert, N. / Van Vlierberghe, H. et al. | 2009
- 604
-
Angiogenesis in liver diseaseFernandez, M. / Semela, D. / Bruix, J. / Colle, I. / Pinzani, M. / Bosch, J. et al. | 2009
- 621
-
Progression of HCV infection in patients with chronic kidney diseaseCholongitas, E. / Manousou, P. / Samonakis, D. / Burroughs, A. K. et al. | 2009
- 622
-
Progression of HCV infection in patients with chronic kidney disease: ReplyMartin, P. / Fabrizi, F. et al. | 2009
- 622
-
Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipientsGerolami, R. / Moal, V. / Picard, C. / Colson, P. et al. | 2009
- 625
-
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graftLoggi, E. / Bihl, F. / Chisholm, J. V. / Biselli, M. / Bontadini, A. / Vitale, G. / Ercolani, G. / Grazi, G. L. / Pinna, A. D. / Bernardi, M. et al. | 2009
- 631
-
Hepatic microcirculation - A critical but neglected factor for the outcome of viral hepatitisSpengler, U. et al. | 2009
- 633
-
When lightning strikes twice: The plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosisFickert, P. / Trauner, M. et al. | 2009
- 636
-
Corrigendum to "Analysis of IL-10, IL-4 and TNF-a polymorphisms in drug-induced liver injury (DILI) and its outcome" [J Hepatol 49 (2008) 107-114]Pachkoria, K. / Lucena, M. I. / Crespo, E. / Ruiz-Cabello, F. / Lopez-Ortega, S. / Fernandez, M. c. / Romero-Gomez, M. / Madrazo, A. / Duran, J. A. / de Dios, A. M. et al. | 2009
- 639
-
To friends who have passed awayPawlotsky, J. M. et al. | 2009
- 640
-
Professor Jean-Pierre BenhamouValla, D. C. / Dhumeaux, D. et al. | 2009
- 642
-
Andres T. Blei, MD| 2009
- 644
-
Partial virological response to nucleos(t)ide analogues in naive patients with chronic hepatitis B: From guidelines to field practiceLampertico, P. et al. | 2009
- 648
-
Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the futureCamma, C. / Petta, S. et al. | 2009
- 652
-
Antiviral therapy in HCV-infected cirrhotics awaiting liver transplantation: A costly strategy for mixed virological resultsRoche, B. / Samuel, D. et al. | 2009
- 655
-
Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectivenessSulkowski, M. et al. | 2009
- 659
-
Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markersMarrero, J. A. et al. | 2009
- 662
-
Who should get a liver graft?Clavien, P. A. et al. | 2009
- 674
-
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapyReijnders, J. G. / Pas, S. D. / Schutten, M. / de Man, R. A. / Janssen, H. L. et al. | 2009
- 684
-
Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patientsMerchante, N. / de los Santos-Gil, I. / Merino, D. / Gonzalez-Serrano, M. / Mira, J. A. / Sanz-Sanz, J. / Fernandez-Fuertes, E. / Ruiz-Morales, J. / Valle, J. d. / Macias, J. et al. | 2009
- 693
-
Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variabilityWeseslindtner, L. / Neumann-Haefelin, C. / Viazov, S. / Haberstroh, A. / Kletzmayr, J. / Aberle, J. H. / Timm, J. / Ross, S. R. / Klauser-Braun, R. / Baumert, T. F. et al. | 2009
- 705
-
Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infectionKim, K. A. / Lin, W. / Tai, A. W. / Shao, R. X. / Weinberg, E. / De Sa Borges, C. B. / Bhan, A. K. / Zheng, H. / Kamegaya, Y. / Chung, R. T. et al. | 2009
- 712
-
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patientsDai, C. Y. / Huang, J. F. / Hsieh, M. Y. / Hou, N. J. / Lin, Z. Y. / Chen, S. C. / Wang, L. Y. / Chang, W. Y. / Chuang, W. L. et al. | 2009
- 719
-
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective studyCarrion, J. A. / Martinez-Bauer, E. / Crespo, G. / Ramirez, S. / Perez-del-Pulgar, S. / Garcia-Valdecasas, J. C. / Navasa, M. / Forns, X. et al. | 2009
- 729
-
Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levelsKumada, T. / Toyoda, H. / Kiriyama, S. / Sone, Y. / Tanikawa, M. / Hisanaga, Y. / Kanamori, A. / Atsumi, H. / Takagi, M. / Nakano, S. et al. | 2009
- 736
-
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalite 2005 studySalmon-Ceron, D. / Rosenthal, E. / Lewden, C. / Bouteloup, V. / May, T. / Burty, C. / Bonnet, F. / Costagliola, D. / Jougla, E. / Semaille, C. et al. | 2009
- 746
-
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinomaDi Tommaso, L. / Destro, A. / Seok, J. Y. / Balladore, E. / Terracciano, L. / Sangiovanni, A. / Iavarone, M. / Colombo, M. / Jang, J. J. / Yu, E. et al. | 2009
- 755
-
Leukocyte transmigration in inflamed liver: A role for endothelial cell-selective adhesion moleculeKhandoga, A. / Huettinger, S. / Khandoga, A. G. / Li, H. / Butz, S. / Jauch, K. W. / Vestweber, D. / Krombach, F. et al. | 2009
- 766
-
miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosisGuo, C. J. / Pan, Q. / Li, D. G. / Sun, H. / Liu, B. W. et al. | 2009
- 779
-
Generation of cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope modificationHuang, Y. H. / Wu, J. C. / Peng, W. L. / Huo, T. I. / Shih, H. H. / Lan, K. H. / Su, C. W. / Lee, S. D. et al. | 2009
- 789
-
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASHCaballero, F. / Fernandez, A. / De Lacy, A. M. / Fernandez-Checa, J. C. / Caballeria, J. / Garcia-Ruiz, C. et al. | 2009
- 797
-
Influence of ethnicity on histological differences in non-alcoholic fatty liver diseaseMohanty, S. R. / Troy, T. N. / Huo, D. / O'Brien, B. L. / Jensen, D. M. / Hart, J. et al. | 2009
- 805
-
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis BChen, D. S. et al. | 2009
- 817
-
Clinical trial design and evidence-based outcomes in the study of liver diseasesCroswell, J. M. / Kramer, B. S. et al. | 2009
- 827
-
Autoimmunity in primary biliary cirrhosis: An alternative view at initiation and function of anti-mitochondrial autoantibodiesBerg, P. A. et al. | 2009
- 828
-
What is the actual role of diagnosis and how to assess it?Colli, A. / Fraquelli, M. et al. | 2009
- 829
-
What is the actual role of diagnosis and how to assess it: ReplyMehta, S. H. / Lau, B. / Afdhal, N. H. / Thomas, D. L. et al. | 2009
- 831
-
Surgical management of portal hypertension in Felty's syndrome: A case report and literature reviewStock, H. / Kadry, Z. / Smith, J. P. et al. | 2009
- 836
-
MELD-Na as a prognostic score for cirrhotic patients: Hyponatremia and ascites are back in the gameSamuel, D. et al. | 2009
- 838
-
Are pigs more human than mice?Elferink, R. O. / Beuers, U. et al. | 2009
- 843
-
Albert Geerts One of the "young boys"Pinzani, M. / Rombouts, K. / Mondelli, M. U. et al. | 2009
- 845
-
Hepatitis C virus and its complex interplay with hepatic glucose and lipid metabolismBartosch, B. et al. | 2009
- 848
-
Portal hypertension and development of hepatocellular carcinoma: Factors influencing significance in prognostic modelsChristensen, E. et al. | 2009
- 850
-
Clinical research in hepatocellular carcinoma: Study design and endpointsForner, A. / Roayaie, S. et al. | 2009
- 854
-
Prevention of hepatocellular carcinoma: The holy grail of hepatitis B treatmentSherman, M. et al. | 2009
- 857
-
Uncoupling proteins and non-alcoholic fatty liver diseaseCortez-Pinto, H. / Machado, M. V. et al. | 2009
- 861
-
Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replicationSauter, D. / Himmelsbach, K. / Kriegs, M. / Carvajal Yepes, M. / Hildt, E. et al. | 2009
- 872
-
Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytesDionisio, N. / Garcia-Mediavilla, M. V. / Sanchez-Campos, S. / Majano, P. L. / Benedicto, I. / Rosado, J. A. / Salido, G. M. / Gonzalez-Gallego, J. et al. | 2009
- 883
-
HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transportersKasai, D. / Adachi, T. / Deng, L. / Nagano-Fujii, M. / Sada, K. / Ikeda, M. / Kato, N. / Ide, Y. H. / Shoji, I. / Hotta, H. et al. | 2009
- 895
-
Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacyChen, L. / Zhang, Q. / Yu, D. m. / Wan, M. b. / Zhang, X. x. et al. | 2009
- 906
-
Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsisTsai, M. H. / Peng, Y. S. / Chen, Y. C. / Lien, J. M. / Tian, Y. C. / Fang, J. T. / Weng, H. H. / Chen, P. C. / Yang, C. W. / Wu, C. S. et al. | 2009
- 916
-
High levels of factor VIII and risk of extra-hepatic portal vein obstructionMartinelli, I. / Primignani, M. / Aghemo, A. / Reati, R. / Bucciarelli, P. / Fabris, F. / Battaglioli, T. / Dell'Era, A. / Mannucci, P. M. et al. | 2009
- 923
-
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosisRipoll, C. / Groszmann, R. J. / Garcia-Tsao, G. / Bosch, J. / Grace, N. / Burroughs, A. / Planas, R. / Escorsell, A. / Garcia-Pagan, J. C. / Makuch, R. et al. | 2009
- 929
-
Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injuryZeng, S. / Dun, H. / Ippagunta, N. / Rosario, R. / Zhang, Q. Y. / Lefkowitch, J. / Yan, S. F. / Schmidt, A. M. / Emond, J. C. et al. | 2009
- 937
-
Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioningCescon, M. / Carini, R. / Grazi, G. / Caraceni, P. / Alchera, E. / Gasloli, G. / Ravaioli, M. / Tuci, F. / Imarisio, C. / Ponte, C. D. et al. | 2009
- 948
-
Elevated expression of DKK1 is associated with cytoplasmic/nuclear b-catenin accumulation and poor prognosis in hepatocellular carcinomasYu, B. / Yang, X. / Xu, Y. / Yao, G. / Shu, H. / Lin, B. / Hood, L. / Wang, H. / Yang, S. / Gu, J. et al. | 2009
- 958
-
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosageLiu, C. J. / Lee, P. H. / Lin, D. Y. / Wu, C. C. / Jeng, L. B. / Lin, P. W. / Mok, K. T. / Lee, W. C. / Yeh, H. Z. / Ho, M. C. et al. | 2009
- 969
-
Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanismGiovannini, C. / Gramantieri, L. / Chieco, P. / Minguzzi, M. / Lago, F. / Pianetti, S. / Ramazzotti, E. / Marcu, K. B. / Bolondi, L. et al. | 2009
- 980
-
Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patientsZhang, J. P. / Yan, J. / Xu, J. / Pang, X. H. / Chen, M. S. / Li, L. / Wu, C. / Li, S. P. / Zheng, L. et al. | 2009
- 990
-
Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screeningRobotin, M. C. / Kansil, M. / Howard, K. / George, J. / Tipper, S. / Dore, G. J. / Levy, M. / Penman, A. G. et al. | 2009
- 999
-
Substituted imidazopyridines as potent inhibitors of HCV replicationVliegen, I. / Paeshuyse, J. / De Burghgraeve, T. / Lehman, L. S. / Paulson, M. / Shih, I. H. / Mabery, E. / Boddeker, N. / De Clercq, E. / Reiser, H. et al. | 2009
- 1010
-
Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy - An extended haplotype of genetic variants increases risk in indinavir treatmentLankisch, T. O. / Behrens, G. / Ehmer, U. / Mobius, U. / Rockstroh, J. / Wehmeier, M. / Kalthoff, S. / Freiberg, N. / Manns, M. P. / Schmidt, R. E. et al. | 2009
- 1019
-
HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: A novel mechanism for NAFLDJin, X. / Yang, Y. d. / Chen, K. / Lv, Z. y. / Zheng, L. / Liu, Y. p. / Chen, S. h. / Yu, C. h. / Jiang, X. y. / Zhang, C. y. et al. | 2009
- 1029
-
Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional studyLi, Y. / Xu, C. / Yu, C. / Xu, L. / Miao, M. et al. | 2009
- 1035
-
Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: A study in monozygotic and dizygotic twinsMakkonen, J. / Pietilainen, K. H. / Rissanen, A. / Kaprio, J. / Yki-Jarvinen, H. et al. | 2009
- 1043
-
Hepatitis D: Thirty years afterRizzetto, M. et al. | 2009
- 1051
-
Hepatectomy versus radiofrequency ablation for early hepatocellular carcinomaFujita, T. et al. | 2009
- 1052
-
Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma: ReplyHasegawa, K. / Makuuchi, M. / Kudo, M. / Okazaki, M. et al. | 2009
- 1053
-
Intraperitoneal application of caffeine prevents d-galactosamine-induced hepatic expression of connective tissue growth factor (CTGF/CCN2) in the ratGressner, O. A. / Siluschek, M. / Lahme, B. / Gressner, A. M. et al. | 2009
- 1055
-
Endothelin-receptor antagonist/N-acetylcysteine combination in type 1 hepatorenal syndromeIzzedine, H. / Kheder-Elfekih, R. / Deray, G. / Thabut, D. et al. | 2009
- 1057
-
Opisthorchiasis mimicking primary biliary cirrhosis as an indication for liver transplantationMelling, N. / Hohenberger, W. / Yedibela, S. et al. | 2009
- 1060
-
Hepatocytes clear platelets and are key regulators of disseminated intravascular coagulation during sepsisSanson, E. / Trautwein, C. et al. | 2009
- 1062
-
Transcriptome analysis of liver cancer: Ready for the clinic?Wang, X. W. / Thorgeirsson, S. S. et al. | 2009
- 1065
-
Corrigendum to "The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: Association with liver disease progression. A prospective cohort study" [J Hepatol 49 (2008) 884-891]Zacharakis, G. / Koskinas, J. / Kotsiou, S. / Tzara, F. / Vafeiadis, N. / Papoutselis, M. / Maltezos, E. / Sivridis, E. / Papoutselis, K. et al. | 2009
- 1067
-
Secretary General's FarewellPawlotsky, J. M. et al. | 2009
- 1071
-
Vitamin D receptor polymorphisms in primary biliary cirrhosis: A functional connection?Adorini, L. et al. | 2009
- 1074
-
Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patientsBottero, J. / Lacombe, K. / Guechot, J. / Serfaty, L. / Miailhes, P. / Bonnard, P. / Wendum, D. / Molina, J. M. / Lascoux-Combe, C. / Girard, P. M. et al. | 2009
- 1084
-
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up studyMoucari, R. / Korevaar, A. / Lada, O. / Martinot-Peignoux, M. / Boyer, N. / Mackiewicz, V. / Dauvergne, A. / Cardoso, A. C. / Asselah, T. / Nicolas-Chanoine, M. H. et al. | 2009
- 1093
-
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis CFerri, S. / Muratori, L. / Quarneti, C. / Muratori, P. / Menichella, R. / Pappas, G. / Granito, A. / Ballardini, G. / Bianchi, F. B. / Lenzi, M. et al. | 2009
- 1102
-
Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cellsTrappoliere, M. / Caligiuri, A. / Schmid, M. / Bertolani, C. / Failli, P. / Vizzutti, F. / Novo, E. / Manzano, C. d. / Marra, F. / Loguercio, C. et al. | 2009
- 1112
-
Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivoLai, J. P. / Sandhu, D. S. / Moser, C. D. / Cazanave, S. C. / Oseini, A. M. / Shire, A. M. / Shridhar, V. / Sanderson, S. O. / Roberts, L. R. et al. | 2009
- 1122
-
A systems biology perspective on cholangiocellular carcinoma development: Focus on MAPK-signaling and the extracellular environmentWang, C. / Maass, T. / Krupp, M. / Thieringer, F. / Strand, S. / Worns, M. A. / Barreiros, A. P. / Galle, P. R. / Teufel, A. et al. | 2009
- 1132
-
Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTENVinciguerra, M. / Carrozzino, F. / Peyrou, M. / Carlone, S. / Montesano, R. / Benelli, R. / Foti, M. et al. | 2009
- 1142
-
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysisRaimondi, S. / Bruno, S. / Mondelli, M. U. / Maisonneuve, P. et al. | 2009
- 1155
-
Activated liver dendritic cells generate strong acquired immunity in a-galactosylceramide treatmentSasakawa, A. / Tatsumi, T. / Takehara, T. / Yamaguchi, S. / Yamamoto, M. / Ohkawa, K. / Miyagi, T. / Hayashi, N. et al. | 2009
- 1163
-
Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patientsZhang, Z. / Jin, B. / Zhang, J. Y. / Xu, B. / Wang, H. / Shi, M. / Wherry, E. J. / Lau, G. K. / Wang, F. S. et al. | 2009
- 1174
-
Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosisLi, C. / Kong, Y. / Wang, H. / Wang, S. / Yu, H. / Liu, X. / Yang, L. / Jiang, X. / Li, L. et al. | 2009
- 1184
-
Ethanol-induced liver injury and changes in sulfur amino acid metabolomics in glutathione peroxidase and catalase double knockout miceKim, S. J. / Lee, J. W. / Jung, Y. S. / Kwon, D. Y. / Park, H. K. / Ryu, C. S. / Kim, S. K. / Oh, G. T. / Kim, Y. C. et al. | 2009
- 1192
-
PPARd agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repairPang, M. / de la Monte, S. M. / Longato, L. / Tong, M. / He, J. / Chaudhry, R. / Duan, K. / Ouh, J. / Wands, J. R. et al. | 2009
- 1202
-
Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populationsTanaka, A. / Nezu, S. / Uegaki, S. / Kikuchi, K. / Shibuya, A. / Miyakawa, H. / Takahashi, S. i. / Bianchi, I. / Zermiani, P. / Podda, M. et al. | 2009
- 1210
-
Autoimmune hepatitis in Italy: The Bologna experienceMuratori, P. / Granito, A. / Quarneti, C. / Ferri, S. / Menichella, R. / Cassani, F. / Pappas, G. / Bianchi, F. B. / Lenzi, M. / Muratori, L. et al. | 2009
- 1219
-
Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidinRuivard, M. / Laine, F. / Ganz, T. / Olbina, G. / Westerman, M. / Nemeth, E. / Rambeau, M. / Mazur, A. / Gerbaud, L. / Tournilhac, V. et al. | 2009
- 1226
-
Deletion of angiotensin II type I receptor reduces hepatic steatosisNabeshima, Y. / Tazuma, S. / Kanno, K. / Hyogo, H. / Chayama, K. et al. | 2009
- 1236
-
Polyenephosphatidylcholine prevents alcoholic liver disease in PPARa-null mice through attenuation of increases in oxidative stressOkiyama, W. / Tanaka, N. / Nakajima, T. / Tanaka, E. / Kiyosawa, K. / Gonzalez, F. J. / Aoyama, T. et al. | 2009
- 1247
-
Operational tolerance after liver transplantationOrlando, G. / Soker, S. / Wood, K. et al. | 2009
- 1258
-
Signalling pathways in alcohol-induced liver inflammationMandrekar, P. / Szabo, G. et al. | 2009
- 1267
-
Liver biopsy: The best standardwhen everything else failsPoynard, T. / Benhamou, Y. / Thabut, D. / Ratziu, V. et al. | 2009
- 1268
-
Liver fibrosis: Screening is not stagingBedossa, P. / Carrat, F. et al. | 2009
- 1269
-
Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin?Serfaty, L. / Fartoux, L. / Poupon, R. et al. | 2009
- 1271
-
Correction of insulin resistance in chronic hepatitis C patients not responding to the standard of care: More questions than answersNegro, F. et al. | 2009
- 1273
-
Acute hepatitis caused by a natural lipid-lowering product: When "alternative" medicine is no "alternative" at allGrieco, A. / Miele, L. / Pompili, M. / Biolato, M. / Vecchio, F. M. / Grattagliano, I. / Gasbarrini, G. et al. | 2009
- 1278
-
Genome-wide association studies reach hepatologyKarlsen, T. H. et al. | 2009
- 1280
-
HALT-C in the final analysis: A molehill out of a mountainAlmasio, P. L. et al. | 2009
- 1283
-
Corrigendum to "96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B":J Hepatol 48 (2008) 714-720Hui, C. K. / Zhang, H. Y. / Bowden, S. / Locarnini, S. / Luk, J. M. / Leung, K. W. / Yueng, Y. H. / Wong, A. / Rousseau, F. / Yuen, K. Y. et al. | 2009
- II
-
Guide for Authors| 2009
- III
-
Volume Contents| 2009
- S5
-
7 PRECLINICAL CHARACTERIZATION OF PRO 206, AN ORALLY ACTIVE SMALL-MOLECULE HEPATITIS C (HCV) ENTRY INHIBITORQian, D. / Coburn, G. / Han, A. Q. / de Muys, J. M. / Gauss, C. / Provoncha, K. / Canfield, M. / Paul, D. / Mohamed, S. / Moorji, S. et al. | 2009
- S7
-
13 A PHASE 2, RANDOMIZED STUDY OF HCV-796 IN COMBINATION WITH PEGYLATED-INTERFERON (PEG) PLUS RIBAVIRIN (RBV) VERSUS PEG PLUS RBV IN HEPATITIS C VIRUS GENOTYPE-1 INFECTIONPockros, P. / Rodriguez-Torres, M. / Villano, S. / Maller, E. / Chojkier, M. et al. | 2009
- S9
-
18 OUTCOME OF HBeAg-NEGATIVE CHRONIC HEPATITIS B (CHB) 5 YEARS AFTER DISCONTINUATION OF LONG TERM ADEFOVIR DIPIVOXIL (ADV) TREATMENTHadziyannis, S. / Sevastianos, V. / Rapti, I. et al. | 2009
- S10
-
21 TWO YEARS SAFETY AND EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN PATIENTS WITH HBV-INDUCED CIRRHOSISButi, M. / Hadziyannis, S. / Mathurin, P. / Urbanek, P. / Sherman, M. / Strasser, S. / Wang, C. / Petersen, J. / Heathcote, E. J. / Marcellin, P. et al. | 2009
- S11
-
24 HEPATIC STELLATE CELLS SECRETION OF CXCL1 MEDIATES THE TLR4-DEPENDENT LEUKOCYTE HOMING TO THE LIVERJohn, B. / Bigorgne, A. E. / Ebrahimkhani, M. R. / Crispe, I. N. et al. | 2009
- S12
-
27 IMPACT OF DIFFERENTIALLY EXPRESSED MICRORNAS ON MYOFIBROBLASTIC TRANSDIFFERENTIATION OF HEPATIC STELLATE CELLSStrack, I. / Schievenbusch, S. / Riemer, J. / Kwiecinski, M. / Noetel, A. / Scheffler, M. / Wedemeyer, I. / Dienes, H. P. / Odenthal, M. et al. | 2009
- S13
-
30 THE CHEMOKINE RECEPTOR CCR5 MEDIATES THE PROFIBROGENIC ACTIONS OF THE HIV ENVELOPE PROTEIN GP120 IN HUMAN HEPATIC STELLATE CELLSGalastri, S. / Bruno, R. / Sacchi, P. / Cima, S. / Caligiuri, A. / Gessani, S. / Fantuzzi, L. / Pinzani, M. / Marra, F. et al. | 2009
- S15
-
35 HEPATITIS E AS A ZOONOSIS AND THE RELEVANCE FOR LIVER TRANSPLANT RECIPIENTSPischke, S. / Baechlein, C. / Suneetha, P. V. / Raupach, R. / Schlue, J. / Becker, J. U. / Heim, A. / Strassburg, C. P. / Manns, M. P. / Grummer, B. et al. | 2009
- S17
-
40 BIOSAFETY IN EX VIVO GENE THERAPY AND CONDITIONAL ABLATION OF LENTIVIRALLY- TRANSDUCED HEPATOCYTES IN NON-HUMAN PRIMATESMenzel, O. / Birraux, J. / Wildhaber, B. / Jond, C. / Lasne, F. / Habre, W. / Nguyen, T. / Chardot, C. et al. | 2009
- S18
-
43 A FIRST CLINICAL TRIAL OF THERAPEUTIC VACCINATION USING NAKED DNA DELIVERED BY IN VIVO ELECTROPORATION SHOWS ANTIVIRAL EFFECTS IN PATIENTS WITH CHRONIC HEPATITIS CSallberg, M. M. / Frelin, L. / Diepolder, H. / Jung, M. C. / Mathiesen, I. / Fons, M. / Hultcrantz, R. / Carlsson, T. / Weiland, O. et al. | 2009
- S19
-
46 TREATMENT OF EXPERIMENTAL FULMINANT HEPATIC FAILURE (FHF) BY ENDOTELIAL PROGENITOR CELLS (EPC) TRANSDUCED BY AN ADENOVIRUS ENCODING CARDIOTROPHIN-1 (CT-1)Fernandez, V. / Kawa, M. / Iniguez, M. / Berasain, C. / Prieto, J. et al. | 2009
- S22
-
51 RESPONSE RATE ACCORDING TO WHO, RECIST AND EASL CRITERIA AFTER RADIOEMBOLIZATION OF YTTRIUM-90 GLASS MICROSPHERES IN ADVANCED HEPATOCELLULAR CARCINOMA: A EUROPEAN PILOT PHASE II STUDYFouly, A. E. / Ertle, J. / Antoch, G. / Hamami, M. / Paul, A. / Bockisch, A. / Gerken, G. / Hilgard, P. et al. | 2009
- S24
-
56 LONG-TERM EFFICACY OF ROSIGLITAZONE IN NONALCOHOLIC STEATOHEPATITIS (NASH): RESULTS OF THE EXTENSION PHASE OF THE FLIRT-2 TRIALRatziu, V. / Charlotte, F. / Bernhardt, C. / Serfaty, L. / Podevin, P. / Moussalli, J. / Poynard, T. et al. | 2009
- S25
-
59 NAFLD INDEX: A SIMPLE SCREENING TOOL REFLECTING NONALCOHOLIC FATTY LIVER DISEASE IN THE KOREAN POPULATIONLee, J. H. / Kim, D. / Kim, H. J. / Yang, J. I. / Kim, W. / Kim, Y. J. / Yoon, J. H. / Cho, S. H. / Sung, M. W. / Lee, H. S. et al. | 2009
- S27
-
64 EXPRESSION OF BILIARY CELL CYTOKERATIN BY HEPATOCYTES IN NON TUMORAL LIVER BIOPSY IS RELATED TO SUBSEQUENT HEPATOCELLULAR CARCINOMA OCCURRENCE IN HCV RELATED CIRRHOSISNKontchou, G. / Nault, J. C. / Aout, M. / Barget, N. / Tepper, M. / Cichon, C. / Vicaut, E. / Trinchet, J. C. / Beaugrand, M. / Ziol, M. et al. | 2009
- S28
-
67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGEBruix, J. / Raoul, J. L. / Sherman, M. / Shan, M. / Lentini, G. / Nadel, A. / Voliotis, D. / Llovet, J. M. et al. | 2009
- S29
-
70 MODULATION OF THE P53 UBIQUITIN-PROTEASOME DEGRADATION PATHWAY BY URSODEOXYCHOLIC ACIDAmaral, J. D. / Castro, R. E. / Sola, S. / Rodrigues, C. M. et al. | 2009
- S31
-
75 MYOFIBROBLASTS PROVIDE HEDGEHOG PARACRINE SIGNALS THAT DRIVE CHOLANGIOCYTES TO RECRUIT NKT CELLS TO PORTAL TRACTSOmenetti, A. / Syn, W. K. / Jung, Y. / Witek, R. P. / Choi, S. S. / Diehl, A. M. et al. | 2009
- S32
-
78 MODULATION OF THE EPIGENETIC REGULATION OF CCCDNA FUNCTION CONTRIBUTES TO IFNa INHIBITION OF HBV REPLICATIONBelloni, L. / Testoni, B. / Scisciani, C. / Pollicino, T. / Raimondo, G. / Levrero, M. et al. | 2009
- S33
-
81 UPTAKE AND TRAFFICKING OF CELL CULTURE-DERIVED HEPATITIS C VIRUS (HCVCC) IN HUMAN PLASMACYTOID DENDRITIC CELLSLambotin, M. / Thumann, C. / Robinet, E. / Stoll-Keller, F. / Liang, J. T. / Barth, H. / Baumert, T. F. et al. | 2009
- S34
-
84 PATTERNS OF INTERFERON-INDUCED GENES IN LIVER AND PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) DURING THE FIRST 24 HOUR (PHASE 1) TREATMENT IN HCV GENOTYPE 1 PATIENTSLau, D. / Sinha, M. / Zhang, Y. / Shudo, E. / Perelson, A. / Luxon, B. / Lemon, S. / Saito, T. / Gale, M. et al. | 2009
- S35
-
86 SAFETY AND ANTIVIRAL ACTIVITY OF SCH 900518 ADMINISTERED AS MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2B TO NAIVE AND TREATMENT-EXPERIENCED HCV-1 INFECTED PATIENTSReesink, H. / Bergmann, J. / de Bruijne, J. / Weegink, C. / van Lier, J. / van Vliet, A. / Keung, A. / Li, J. / OMara, E. / Treitel, M. et al. | 2009
- S40
-
97 GROWTH OF HEPADNAVIRUS INFECTED HEPATOCYTES STRONGLY REDUCES VIRION PRODUCTIVITY AND CCCDNA LOADS IN UPA MICEVolz, T. / Lutgehetmann, M. / Broja, T. / Lohse, A. W. / Petersen, J. / Dandri, M. et al. | 2009
- S41
-
100 TRANSLOCATION OF BACTERIAL DNA IS ASSOCIATED WITH WORSENING OF THE HYPERKINETIC SYSTEMIC CIRCULATION AND OF INTRA-HEPATIC ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CIRRHOTIC AND ASCITESBellot, P. / Garcia-Pagan, J. C. / Frances, R. / Abraldes, J. G. / Gonzalez-Navajas, J. M. / Navasa, M. / Perez-Mateo, M. / Such, J. / Bosch, J. et al. | 2009
- S42
-
102 EFFECTS OF SATAVAPTAN, AN ORAL VASOPRESSIN V2 RECEPTOR ANTAGONIST, ON MANAGEMENT OF ASCITES AND MORBIDITY IN LIVER CIRRHOSIS IN A LONG-TERM, PLACEBO-CONTROLLED STUDYWong, F. / Bernardi, M. / Horsmans, Y. / Cabrijan, Z. / Watson, H. / Gines, P. et al. | 2009
- S43
-
105 PHASE 2, MULTICENTER, RANDOMIZED STUDY OF AST-120 (SPHERICAL CARBON ADSORBENT) VS. LACTULOSE IN THE TREATMENT OF LOW-GRADE HEPATIC ENCEPHALOPATHY (HE)Pockros, P. / Hassanein, T. / Vierling, J. / Heuman, D. / Hillebrand, D. / Chojkier, M. / Resler, M. / LaPlaca, C. / Harris, M. et al. | 2009
- S44
-
108 CANNABINOID CB2 RECEPTORS STIMULATE LIVER REGENERATIONBelot, M. P. / Teixeira-Clerc, F. / Manin, S. / Deveaux, V. / van Nhieu, J. t. / Zimmer, A. / Mallat, A. / Lotersztajn, S. et al. | 2009
- S48
-
119 HEPATOCYTES AS CYTOTOXIC EFFECTOR CELLS AND THEIR CELL KILLING ACTIVITY DURING PROGRESSION AND RECOVERY FROM HEPADNAVIRUAL HEPATITISGuy, C. S. / Wang, J. / Michalak, T. I. et al. | 2009
- S49
-
122 PD-1/PDL1 PATHWAY IS KEY IN DETERMINING THE BALANCE OF CURATIVE OR DESTRUCTIVE FUNCTION OF VIRUS-SPECIFIC CD8+ T-CELLS IN HBV INFECTIONEvans, A. / Phillips, S. / Riva, A. / Bertoletti, A. / Naoumov, N. / Chokshi, S. et al. | 2009
- S50
-
124 HIGH-DOSE PEGINTERFERON ALFA-2A (40KD) INDUCTION THERAPY AND STANDARD RIBAVIRIN ENHANCES EARLY BUT NOT SUSTAINED VIROLOGICAL RESPONSES IN HCV GENOTYPE 1 PATIENTS: FINAL CHARIOT STUDY RESULTSRoberts, S. / Weltman, M. / Crawford, D. H. / Cheng, W. S. / Sievert, W. / McCaughan, G. / Desmond, P. / Rawlinson, W. / Marks, P. / Yoshihara, M. et al. | 2009
- S51
-
126 HEMOGLOBIN DECLINE IS ASSOCIATED WITH SVR AMONG HCV GENOTYPE 1-INFECTED PERSONS TREATED WITH PEGINTERFERON (PEG)/RIBAVIRIN (RBV): ANALYSIS FROM THE IDEAL STUDYSulkowski, M. / Shiffman, M. / Afdhal, N. / Reddy, R. / McCone, J. / Lee, W. / Herrine, S. / Harrison, S. / Deng, W. / Brass, C. et al. | 2009
- S52
-
129 MORTALITY IN PATIENTS WITH CHRONIC VERSUS CLEARED HCV INFECTION - A NATIONWIDE, POPULATION-BASED COHORT STUDYOmland, L. H. / Krarup, H. / Jepsen, P. / Georgsen, J. / Harritshoj, L. H. / Riisom, K. / Jacobsen, S. E. / Schouenborg, P. / Christensen, P. B. / Sorensen, H. T. et al. | 2009
- S53
-
131 A STUDY ON A RABBIT MODEL OF STEATOHEPATITIS WITH ADVANCED FIBROSISKawada, N. / Ogawa, T. / Shiga, R. et al. | 2009
- S54
-
134 DECREASED HEPATIC MACROPHAGE INFILTRATION, INSULIN RESISTANCE AND TNFa-INDUCED HEPATOCYTE DAMAGE IN APOE/5-LIPOXYGENASE DOUBLE KNOCKOUT MICEMartinez-Clemente, M. / Ferre, N. / Lopez-Parra, M. / Horrillo, R. / Gonzalez-Periz, A. / Titos, E. / Moran-Salvador, E. / Miquel, R. / Arroyo, V. / Funk, C. D. et al. | 2009
- S55
-
137 UNSATURATED FATTY ACIDS PROMOTE HEPATOMA PROLIFERATION AND PROGRESSION THROUGH DOWNREGULATION OF THE TUMOR SUPPRESSOR PTENVinciguerra, M. / Carrozzino, F. / Carlone, S. / Montesano, R. / Benelli, R. / Foti, M. et al. | 2009
- S58
-
143 SAFETY AND EFFICACY OF STEROID- FREE IMMUNOSUPPRESSION POST-LIVER TRANSPLANTATION: A RANDOMISED PHASE III TRIAL COMPARING TACROLIMUS MONOTHERAPY AFTER DACLIZUMAB INDUCTION VERSUS TACROLIMUS+MMF DUAL THERAPYBilbao, I. / Otto, G. / Becker, T. / DAmico, D. / Colledan, M. / Bernardos, A. / Beckebaum, S. / Isoniemi, H. / Pirenne, J. / Jaray, J. et al. | 2009
- S63
-
147 CASPASE ACTIVATION IS ASSOCIATED WITH SPONTANEOUS RECOVERY FROM ACUTE LIVER FAILUREVolkmann, X. / Anstaett, M. / Hadem, J. / Bahr, M. / Manns, M. / Bantel, H. et al. | 2009
- S64
-
150 INSULIN-LIKE GROWTH FACTOR-II (IGF-II) IMPROVES OXIDATIVE LIVER DAMAGE AND LIPID METABOLISM IN AGING RATSCastilla-Cortazar, I. / Garcia-Fernandez, M. / Sierra, I. / Puche, J. E. / Delgado, G. / Guerra, L. / Gonzalez-Baron, S. et al. | 2009
- S65
-
153 THE EFFICACY OF ISCHEMIC PRECONDITIONING IN PROTECTING HUMAN TRANSPLANTED LIVER FROM ISCHEMIA/REPERFUSION INJURY IS ASSOCIATED TO THE ACTIVATION OF PHOSPHOINOSITIDE-3KINASECescon, M. / Carini, R. / Grazi, G. / Caraceni, P. / Alchera, E. / Gasloli, G. / Ravaioli, M. / Tuci, F. / Imarisio, C. / Ponte, C. D. et al. | 2009
- S66
-
156 SUBNORMOTHERMIC MACHINE PERFUSION REDUCES PRESERVATION DAMAGE OF LIVERS FROM NON-HEART BEATING DONORS: A NEW CHANGE FOR EXPANDING THE DONOR POOL?Ferrigno, A. / Rizzo, V. / Bonconpagni, E. / Richelmi, P. / Neri, D. / Gringeri, E. / Freitas, I. / Cillo, U. / Vairetti, M. et al. | 2009
- S67
-
159 EFFECTS OF ISCHEMIC PRE- AND POSTCONDITIONING ON HIF-1a, VEGF AND TGF-b EXPRESSION DURING WARM LIVER ISCHEMIA AND REPERFUSIONKnudsen, A. / Kannerup, A. S. / Gronbaek, H. / Funch-Jensen, P. / Frystyk, J. / Flyvbjerg, A. / Mortensen, F. V. et al. | 2009
- S71
-
170 MODEL OF IMPAIRED ENERGETIC STATUS TO REPRODUCE CELLULAR STRESS OF HEPATOCYTEVincourt, V. / Escriou, V. / Largeau, C. / Scherman, D. / Cynober, L. / Chaumeil, J. C. / Dumortier, G. et al. | 2009
- S72
-
173 CHANGES OF GUT BACTERIAL ECOSYSTEM AND ITS EFFECT ON IMMUNO-SYSTEM IN PATIENTS WITH BOTH LIVER TRANSPLANTATION AND LIVER CIRRHOSISWu, Z. / Lu, H. / Li, L. et al. | 2009
- S73
-
176 PROGNOSTIC ASSESSMENT OF EARLY MORTALITY AFTER ACUTE VARICEAL HAEMORRHAGE BASED ON CLASSIFICATION AND REGRESSION TREE ANALYSISAugustin, S. / Muntaner, L. / Altamirano, J. / Saperas, E. / Gonzalez, A. / Genesca, J. et al. | 2009
- S74
-
178 COMPARISON OF ULTRASONOGRAPHIC EVALUATION OF LIVER SURFACE AND TRANSIENT ELASTOGRAPHY IN THE DIAGNOSIS OF CIRRHOSIS AND PORTAL HYPERTENSIONBerzigotti, A. / Abraldes, J. G. / Llop, E. / Erice, E. / Gilabert, R. / Garcia-Pagan, J. C. / Bosch, J. et al. | 2009
- S76
-
183 THE MIND AND LIVER TEST: A FRESHLY DESIGNED PSYCHOMETRIC TEST, TOWARDS A GOLD STANDARD IN THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHYDas, S. / Jayanthi, V. et al. | 2009
- S77
-
186 EFFECTS OF PIOGLITAZONE ON PORTAL AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH ADVANCED LIVER CIRRHOSIS: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIALFerlitsch, A. / Pleiner, J. / Homoncik, M. / Reiberger, T. / Schaller, G. / Mittermayer, F. / Wolzt, M. / Peck-Radosavljevic, M. et al. | 2009
- S79
-
192 OBLITERATIVE PORTAL VENOPATHY (OPV): A RETROSPECTIVE STUDY OF 59 PATIENTSHillaire, S. / Cazals-Hatem, D. / Rudler, M. / Denninger, M. H. / Plessier, A. / Francoz, C. / Durand, F. / Bedossa, P. / Valla, D. et al. | 2009
- S81
-
198 SOCIOECONOMIC STATUS AND MORTALITY AMONG CIRRHOSIS PATIENTS: A DANISH NATIONWIDE COHORT STUDYJepsen, P. / Vilstrup, H. / Andersen, P. K. / Sorensen, H. T. et al. | 2009
- S82
-
201 CORTICOSTEROIDS IMPROVE 28-DAY SURVIVAL IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS: INDIVIDUAL DATA ANALYSIS OF THE LAST 5 RANDOMIZED CONTROLLED TRIALSMathurin, P. / OGrady, J. / Carithers, R. L. / Phillips, M. / Ramond, M. J. / Louvet, A. / Castel, H. / Naveau, S. / Morgan, T. / Maddrey, W. C. et al. | 2009
- S83
-
204 INCREASED VENOUS PRESSURE INCREASES LIVER STIFFNESS (FIBROSCAN) INDEPENDENT OF LIVER FIBROSISMillonig, G. / Friedrich, S. / Adolf, S. / Poschl, G. / Stiefel, P. / Seitz, H. K. / Mueller, S. et al. | 2009
- S84
-
207 SAFETY OF RIFAXIMIN IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A RANDOMIZED, PHASE 3, PLACEBO-CONTROLLED CLINICAL TRIALMullen, K. / Sigal, S. / Sheikh, M. / Bass, N. / Poordad, F. / Merchant, K. / Huang, S. / Shaw, A. / Bortey, E. / Forbes, W. et al. | 2009
- S86
-
212 USE OF THE SX-ELLA SELF-EXPANDING MESH METAL STENT IN THE MANAGEMENT OF COMPLEX VARICEAL HAEMORRHAGE: INITIAL EXPERIENCE IN A SINGLE CENTREHogan, B. / Patch, D. / Burroughs, A. / OBeirne, J. et al. | 2009
- S87
-
215 LIVER STIFFNESS VALUES MEASURED BY TRANSIENT ELASTOGRAPHY ARE INCREASED IN PATIENTS WITH ACUTELY DECOMPENSATED HEART FAILUREPozzoni, P. / Prati, D. / Berzuini, A. / Gerosa, A. / Canovi, C. / Molteni, E. E. / Barbarini, M. / Bonino, F. / Colli, A. et al. | 2009
- S89
-
220 PREDICTIVE FACTORS OF TRANSPLANT FREE SURVIVAL IN PATIENTS WITH FULMINANT AND SUBFULMINANT HEPATIC FAILURE: RESULTS FROM A RANDOMIZED CONTROLLED MULTICENTER TRIALSaliba, F. / Camus, C. / Durand, F. / Mathurin, P. / Delafosse, B. / Barange, K. / Perrigault, P. F. / Revel, P. / Serfaty, L. / Belnard, M. et al. | 2009
- S92
-
228 SECONDARY BACTERIAL PERITONITIS IN CIRRHOSIS: A SERIES OF 24 PATIENTS COMPARED TO 124 EPISODES OF SPONTANEOUS BACTERIAL PERITONITISAlvarez, C. / Castellote, J. / Soriano, G. / Girbau, A. / Gordillo, J. / Baliellas, C. / Casas, M. / Pons, C. / Roman, E. M. / Maisterra, S. et al. | 2009
- S94
-
234 THE ROLE OF SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) IN HEPATIC ENCEPHALOPATHYWeisberg, I. S. / Jesudian, A. B. / Barboza, K. C. / Liu, T. / Bosworth, B. P. / Sigal, S. H. et al. | 2009
- S95
-
236 SELECTIVE INTRAHEPATIC ARTERIAL INFUSION OF AN ENDOTHELIN-A (ET-A)-RECEPTOR INHIBITOR INCREASES THE HEPATIC ARTERIAL FLOW AND DECREASES THE PORTAL VENOUS PRESSURE IN DECOMPENSATED CIRRHOTIC PATIENTSZipprich, A. / Dollinger, M. M. / Winkler, M. / Kleber, G. / Fleig, W. E. et al. | 2009
- S96
-
239 EVIDENCE FOR AN LKB1/AMPK/ENOS CASCADE REGULATED BY HGF, S-ADENOSYLMETHIONINE, AND NO IN HEPATOCYTE PROLIFERATIONEmbade, N. / Vazquez, M. / Varela-Rey, M. / Martinez, N. / Fernandez, D. / Gomez, L. / Lamas, S. / Lu, S. / Mato, J. M. / Martinez-Chantar, M. L. et al. | 2009
- S97
-
242 ACTIVATION OF PI3K P110 GAMMA MEDIATES BILE SALT-INDUCED APOPTOSISHohenester, S. / Wimmer, R. / Beuers, U. / Webster, C. / Rust, C. et al. | 2009
- S98
-
245 ALPHA-FETOPROTEIN HARBORS A FUNCTON FOR ALLEVIATING APOPTOSIS INDUCED BY ALL TRANS RETINOIC ACID IN HEPATOMA CELLSLi, M. / Liu, X. / Zhou, S. / Li, G. et al. | 2009
- S99
-
248 PROTECTIVE ROLE OF DIMETHYL-DIPHENYL- BICARBOXYLATE (DDB) ON APOPTOTIC REGULATORS IN HEPATIC ISCHEMIA REPERFUSION INJURY (IRI) ANIMAL MODELNaguib, M. / Zaki, A. / Heikal, O. / Kassem, L. / Mahran, L. et al. | 2009
- S101
-
254 CHARACTERIZATION OF CD133-POSITIVE RADIORESISTANT CELLS IN HEPATOCELLULAR CARCINOMA CELLSYoon, S. K. / Piao, L. S. / Hur, W. / Kim, J. D. / Yang, J. M. / Choi, S. W. / Han, N. I. / Lee, C. D. / Lee, Y. S. et al. | 2009
- S105
-
265 EFFECT OF DIETARY CHOLESTEROL ON GALLBLADDER BILE LITHOGENICITY AND GENE EXPRESSION IN THE ENTEROHEPATIC AXIS OF NON-OBESE GALLSTONE AND CONTROL WOMENMiquel, J. F. / Pimentel, F. / Lammert, F. / Lutjohann, D. / Azocar, L. / Molina, H. / Cuevas, A. / Reyes, S. / Arrese, M. / Nervi, F. et al. | 2009
- S106
-
268 THE EFFECT OF LOCAL PH AND PLASMA MEMBRANE POTENTIAL ON TRANSPORT FUNCTION OF HUMAN AND RAT ORGANIC ANION-TRANSPORTING POLYPEPTIDES ISOFORMS INVOLVED IN LIVER DRUG UPTAKEMartinez-Becerra, P. / Briz, O. / Romero, M. R. / Macias, R. I. / Perez, M. J. / Fernandez-Abalos, J. M. / Gonzalez-Sanchez, M. E. / Garcia Marin, J. J. et al. | 2009
- S107
-
271 ZO-1 AND OCCLUDIN AND E-CADHERIN EXPRESSIONS IN BILIARY TRACT CANCERSNemeth, Z. / Szasz, A. M. / Tatrai, P. / Nemeth, J. / Somoracz, A. / Szijarto, A. / Kiss, A. / Schaff, Z. et al. | 2009
- S108
-
274 DEFICIENCY OF NIEMANN-PICK C1 PROTEIN EXPRESSION PROTECTS AGAINST DIET-INDUCED GALLSTONE FORMATION IN MICEMorales, M. G. / Amigo, L. / Castro, J. / Nervi, F. / Rigotti, A. / Zanlungo, S. et al. | 2009
- S110
-
281 THE NEURONAL GUIDANCE CUE AND SURVIVAL FACTOR, NETRIN-1, IN LIVER FIBROGENESISLopez, D. / Scheffler, M. / Schulze, F. / Wendland, K. / Mesghenna, S. / Tox, U. / Drebber, U. / Nierhoff, D. / Dienes, H. P. / Odenthal, M. et al. | 2009
- S111
-
284 PIRFENIDONE LIMITS TH2 FIBROGENIC RESPONSE IN EXPERIMENTAL LIVER FIBROSIS VIA P38 MAPK INHIBITIONNavarro-Partida, J. / Marquez-Aguirre, A. L. / Galvez-Gastelum, J. / Bueno-Topete, M. R. / Gonzalez-Cuevas, J. / Armendariz-Borunda, J. et al. | 2009
- S112
-
287 FUNCTIONAL STUDEIS IN PRIMARY HEPATOCYTES: THE RELATIONSHIP BETWEEN CD147 EXPRESSION AND MATRIX METALLOPROTEINASE (MMP) ACTIVITYRichardson, S. / Patkunanathan, B. / Warner, F. / McLennan, S. / McCaughan, G. / Shackel, N. et al. | 2009
- S114
-
292 TOLL-LIKE RECEPTOR STIMULATION OF HEPATIC STELLATE CELLS LEADS TO UP-REGULATION OF CO-STIMULATORY MOLECULES AND INDUCTION OF FIBROSIS-RELATED GENESWang, B. / Meng, Z. / Gerken, G. / Schlaak, J. et al. | 2009
- S115
-
295 LIVER FIBROSIS IS INDUCED BY INSULIN RESISTANCE BY ENHANCING THE DUCTULAR REACTION THAT UNDERGO EPITHELIAL-MESENCHYMAL TRANSITION IN CHRONIC HEPATITIS CSvegliati-Baroni, G. / Faraci, G. / Saccomanno, S. / Fabris, L. / Cadamuro, M. / Strazzabosco, M. / Bugianesi, E. / Benedetti, A. / Marchesini, G. et al. | 2009
- S116
-
299 ANALYSIS OF SIGNALING NETWORKS IN PDGF-B MEDIATED LIVER FIBROSISMaass, T. / Thieringer, F. / Becker, K. / Kanzler, S. / Galle, P. R. / Teufel, A. et al. | 2009
- S119
-
306 ASSOCIATION OF MANGANESE SUPEROXIDE DISMUTASE FUNCTIONAL POLYMORPHISM (SOD2 V16A) WITH IDIOSYNCRATIC DRUG-INDUCED LIVER INJURYAndrade, R. J. / Martinez, C. / Ulzurrun, E. / Garcia-Martin, E. / Pelaez, G. / Romero-Gomez, M. / Castiella, A. / Planas, R. / Guarner, C. / Salmeron, J. F. et al. | 2009
- S120
-
309 CYTOTOXIC ACTIVITY OF IMMUNOLOGIC EFFECTOR CELLS INDUCED AGAINST HCC BY AFP- OR TUMOR LYSATE-PULSED DENDRITIC CELLS CAN BE SIGNIFICANTLY ENHANCED BY ADENOVIRAL TRANSDUCTION WITH IL-12Gonzalez-Carmona, M. A. / Vogt, A. / Sievers, E. / Raskopf, E. / Schmidt-Wolf, I. / Schmitz, V. / Sauerbruch, T. / Caselmann, W. H. et al. | 2009
- S122
-
314 INTRATUMORAL TREATMENT WITH DENDRITIC CELLS ENGINEREED TO EXPRESS CD40L OR CD40L AND IL-2 INDUCES INHIBITION OF SUBCUTANEOUS HEPATOCELLULAR TUMOR GROWTH IN MICEVogt, A. / Demmer, W. / Caselmann, W. H. / Sauerbruch, T. / Gonzalez-Carmona, M. A. et al. | 2009
- S123
-
317 DYSREGULATION OF GLUCONEOGENESIS IN CHRONIC HEPATITIS C: THE ROLE OF PROTEIN PHOSPHATASE 2ABernsmeier, C. / Duong, F. H. / Lin, S. / Heim, M. H. et al. | 2009
- S124
-
320 COMPETITION BETWEEN DIVERGENT HEPATITIS C VIRUS STRAINS DRIVEN BY INTERNAL RIBOSOME ENTRY SITE EFFICIENCY IN LIVER AND B-CELLSDurand, T. / Colman, H. / Diliberto, G. / Cammas, A. / Marcellin, P. / Vagner, S. / Feray, C. et al. | 2009
- S125
-
323 PRECLINICAL PHARMACOKINETIC AND SAFETY PROFILE OF IDX375, A NOVEL AND POTENT NON-NUCLEOSIDE HCV POLYMERASE INHIBITORGood, S. S. / Bu, C. / Camire, M. / Hernandez-Santiago, B. / Larsson, M. / Rashidzadeh, H. / Pan-Zhou, X. R. / Luo, S. / Selden, J. / Dousson, C. B. et al. | 2009
- S128
-
332 HEPATITIS C VIRUS PROMOTES HUMAN HEPATIC STELLATE CELL MIGRATIONVilchez, S. M. / Munoz, Y. R. / Rodriguez, R. L. / Aldabe, R. / Otero, R. M. / Cameno, P. S. et al. | 2009
- S131
-
342 A MOUSE MODEL WITH LONG TERM EXPRESSION OF HEPATITIS C VIRUS NS3/4A PROTEASE FOR THE PHARMACOKINETIC AND PHARMACODYNAMIC (PK/PD) STUDY OF HCV PROTEASE INHIBITORSLin, J. / Hong, J. / Lim, S. / Qin, X. / Pan, L. / Huang, L. / Liu, J. / Schaefer, C. / Ammons, S. / Seiwert, S. et al. | 2009
- S132
-
345 INHIBITION OF HCV CELL CULTURE INFECTIOUS VIRUS AND DRUG RESISTANT REPLICONS BY INTRABODIESGal-Tanamy, M. / Zemel, R. / Bachmetov, L. / Jangra, R. / Villanueva, R. / Yi, M. / Lemon, S. / Benhar, I. / Tur-Kaspa, R. et al. | 2009
- S133
-
348 HOMODIMERIZATION OF THE HEPATITIS C VIRUS NON-STRUCTURAL 4B PROTEIN REQUIRES AN INTACT BASIC LEUCINE ZIPPERWelker, M. W. / Welsch, C. / Meyer, A. K. / Forestier, N. / Kronenberger, B. / Lengauer, T. / Piiper, A. / Zeuzem, S. / Sarrazin, C. et al. | 2009
- S134
-
351 THE CHANGES OF INTRAHEPATIC CCCDNA DURING ENTECAVIR OR ADEFOVIR DIPIVOXIL TREATMENT FOR CHRONIC HEPATITIS B PATIENTSCheng, P. N. / Wu, I. C. / Young, K. C. / Chang, T. T. et al. | 2009
- S135
-
354 PREVALENCE OF SIGNIFICANT FIBROSIS AND CORRELATIONS BETWEEN HISTOLOGICAL INFLAMMATION AND FIBROSIS SCORES AND SERUM HEPATITIS B (HBV) DNA LEVELS IN CHRONIC HEPATITIS BCroagh, C. / Bell, S. / Kong, Y. / Chen, R. / Slavin, J. / Locarnini, S. / Desmond, P. et al. | 2009
- S136
-
357 EPIDEMIOLOGICAL AND CLINICAL FEATURES OF HEPATITIS B VIRUS GENOTYPES AMONG A POPULATION OF IMMIGRANTS IN A GEOGRAPHIC AREA OF SOUTHERN ITALYFazio, V. / Scotto, G. et al. | 2009
- S137
-
360 ASSOCIATION STUDY OF IFNAR2 AND IL10RB GENES WITH THE SUSCEPTIBILITY AND INTERFERON RESPONSE IN HBV INFECTIONGong, Q. M. / Kong, X. F. / Yang, Z. T. / Xu, J. / Wang, L. / Li, X. H. / Zhang, D. H. / Jiang, J. H. / Zhang, X. X. et al. | 2009
- S138
-
363 FREQUENT REACTIVATION OF HEPATITIS B VIRUS AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING INTENSIVE TRANSARTERIAL THERAPY: A PROSPECTIVE COMPARISON ANALYSISJang, J. W. / You, C. R. / Kim, J. D. / Kim, C. W. / Choi, J. Y. / Cho, S. H. / Han, J. Y. / Yang, J. M. / Choi, S. W. / Lee, C. D. et al. | 2009
- S140
-
368 DIFFERENCE PROFILES BETWEEN C18-27V/I MUTANTS IN THE PREVALENCE AND IMMUNOGENICITY IN SOUTHERN CHINAMa, S. / Hou, J. et al. | 2009
- S141
-
371 OUTCOME OF CHRONIC HEPATITIS DELTA IN ITALY: A LONG TERM COHORT STUDYNiro, G. A. / Smedile, A. / Ippolito, A. / Ciancio, A. / Fontana, R. / Olivero, A. / Gioffreda, D. / Abate, M. L. / Valvano, M. R. / Andriulli, A. et al. | 2009
- S142
-
374 THE FIB-4 INDEX IS ACCURATE TO ASSESS LIVER FIBROSIS BEFORE AND DURING TREATMENT IN CHRONIC HEPATITIS BNalpas, B. / Mallet, V. / Vallet-Pichard, A. / Fontaine, H. / Pol, S. et al. | 2009
- S143
-
377 LIVER STIFFNES EVALUATED THROUGH TRANSIENT ELASTOGRAPHY IN PATIENTS CHRONICALY INFECTED WITH HBVSporea, I. / Sirli, R. / Deleanu, A. / Tudora, A. / Bota, S. / Cornianu, M. et al. | 2009
- S144
-
380 SERUM HBsAg CONCENTRATION: RELATIONSHIP TO INTRAHEPATIC AND SERUM MARKERS OF HBV REPLICATIONThompson, A. / Nguyen, T. / Gane, E. / Abbott, W. / Lau, G. / Desmond, P. / Bowden, S. / Locarnini, S. et al. | 2009
- S145
-
383 MUTATION ANALYSIS OF HBV PRECORE/BASAL CORE PROMOTER IN PATIENT WITH CHRONIC HEPATITIS B AND HEPATITIS B-RELATED ACUTE-ON-CHRONIC LIVER FAILURERen, X. / Xu, Z. / Liu, Y. / Zhong, Y. / Xu, D. et al. | 2009
- S146
-
386 ASSOCIATION OF HEPATITIS B VIRUS PRE-S DELETIONS WITH THE RISK OF DEVELOPMENT OF HEPATOCELLULAR CARCINOMAYeung, A. P. / Wong, D. K. / Fung, J. / Yuen, J. C. / Fung, F. K. / Lai, C. L. / Yuen, M. F. et al. | 2009
- S147
-
389 HCV INFECTED PATIENTS ARE "SPARED" FROM THE METABOLIC SYNDROME BUT NOT FROM INSULIN RESISTANCEBallestri, S. / Violi, E. / Lonardo, A. / Adinolfi, L. E. / Carulli, L. / Lombardini, S. / Scaglioni, F. / Ricchi, M. / Ruggiero, G. / Loria, P. et al. | 2009
- S148
-
392 LIVER STIFFNESS IS ASSOCIATED WITH CLINICAL OUTCOME OF HCV RELATED CIRRHOSISCardoso, A. C. / Stern, C. / Moucari, R. / Figueiredo-Mendes, C. / Giuily, N. / Marcellin, P. et al. | 2009
- S149
-
395 NON-INVASIVE ASSESSMENT OF HEPATIC LIPID COMPOSITION: LIPID POLYUNSATURATION DECREASES WITH INCREASING FIBROSIS IN CHRONIC HEPATITIS CCobbold, J. F. / Patel, J. H. / Goldin, R. D. / Crossey, M. E. / Fitzpatrick, J. / Taylor-Robinson, S. D. / Cox, I. J. et al. | 2009
- S151
-
401 FATIGUE IN CHRONIC HEPATITIS C INFECTION IS RELATED TO IMMUNE ACTIVATION AND ABNORMALITIES IN TRYPTOPHAN METABOLISMGess, M. / Lee, T. / Tatman, N. / Rahman, T. / Clark, S. / Cowan, M. / Sheldon, J. / Holt, D. / Forton, D. et al. | 2009
- S152
-
404 SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF GS-9450 IN HEALTHY MALE AND FEMALE VOLUNTEERSHoppener, F. / Kim, J. A. / Park, M. J. / Choi, H. J. et al. | 2009
- S154
-
410 FOOD INTAKE INCREASES LIVER STIFFNESS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTIONMederacke, I. / Wursthorn, K. / Rifai, K. / Manns, M. P. / Wedemeyer, H. / Bahr, M. J. et al. | 2009
- S156
-
415 HIGH PREVALENCE OF CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN A GERMAN METROPOLITAN AREA: A PROSPECTIVE SCREENING ANALYSING 7683 PATIENTSSchlosser, B. / Domke, D. / Mockel, M. / Biermer, M. / Fulop, B. / Wiedenmann, B. / Haas, N. / Bail, H. / Muller, C. / Tauber, R. et al. | 2009
- S157
-
418 INFLUENCE OF HEPATITIS C VIRUS (HCV) INFECTION ON ATHEROSCLEROSIS RISK IN HIV-INFECTED ADULTSSilvain, C. / Wangermez, M. / Sosner, P. / Deroode, C. C. / Moal, G. L. et al. | 2009
- S158
-
421 IS LIVER STIFFNESS ACCURATE TO DEFINE REGRESSION OF CIRRHOSIS IN PATIENTS CURED FROM CHRONIC HEPATITIS C?Sultanik, P. / Mallet, V. / Vallet-Pichard, A. / Fontaine, H. / Sogni, P. / Pol, S. et al. | 2009
- S161
-
429 IMPACT OF THE FAMILY SCREENING ON THE LONG-TERM PROGNOSIS OF WILSONS DISEASECervoni, J. P. / Militaru, V. / Miguet, J. P. / Vanlemmens, C. / Woimant, F. / Di Martino, V. et al. | 2009
- S163
-
435 PORTAL HYPERTENSION AND HEPATIC VENOUS- VENOUS COMMUNICATIONS IN PATIENTS WITH BILIARY ATRESIAMiraglia, R. / Luca, A. / Riva, S. / Spada, M. / Maruzzelli, L. / Gridelli, B. / Bosch, J. et al. | 2009
- S164
-
438 SECONDARY AND TERTIARY STRUCTURE MODELING REVEALS EFFECTS OF NOVEL MUTATIONS IN POLYCYSTIC LIVER DISEASE GENES PRKCSH AND SEC63Waanders, E. / De Koning, D. B. / Te Morsche, R. H. / Venselaar, H. / Kamath, P. S. / Torres, V. E. / Somlo, S. / Drenth, J. P. et al. | 2009
- S167
-
442 THE CURRENT PRACTICE OF LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN ITALY: INSIGHTS FROM THE LIVER-MATCH STUDYAngelico, M. / Marianelli, T. / Ricci, A. et al. | 2009
- S168
-
445 INFLUENCE OF REPLACEMENT OF CALCINEURIN- INHIBITOR IMMUNOSUPPRESSORS TO RAPAMYCIN ON HCV VIRAL LOAD AND SERUM TRANSAMINASES LEVEL IN HCV LIVER TRANSPLANT PATIENTSBarcena, R. / Teruel, C. / Garrido, E. / Blesa, C. / Graus, J. / Nuno, J. / Moreno, A. / Mateos, M. L. / Campo, S. d. et al. | 2009
- S169
-
448 PROGNOSTIC VALUE OF TRANSIENT ELASTOGRAPHY FOR THE OUTCOME OF ACUTE LIVER FAILURE (ALF)Dechene, A. / ElFouly, A. / Schlattjan, M. / Gieseler, R. K. / Saner, F. / Paul, A. / Gerken, G. / Canbay, A. E. et al. | 2009
- S170
-
451 CLINICAL, HISTOLOGICAL AND HEMODINAMIC OUTCOMES IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS TREATED WITH PEGILATED INTERFERON PLUS RIBAVIRINCarrion, J. A. / Crespo, G. / Miquel, R. / Garcia-Pagan, J. C. / Bosch, J. / Navasa, M. / Forns, X. et al. | 2009
- S171
-
454 PREDICTORS OF HEPATITIS B VIRUS RECURRENCE WITH EMERGENCE OF YMDD MOTIF MUTANT FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATIONChun, J. / Kim, W. / Kim, J. H. / Kwak, M. S. / Hwang, S. W. / Jung, Y. J. / Jeong, J. B. / Kim, B. G. / Lee, K. L. / Kim, D. H. et al. | 2009
- S173
-
460 TOLERABILITY OF MYCOPHENOLATE MOFETIL IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS: A 10-YEAR SINGLE CENTRE EXPERIENCEDumortier, J. / Guillaud, O. / Adham, M. / Salandre, J. / Boillot, O. et al. | 2009
- S174
-
463 DECREASE IN BRAIN VOLUME FOLLOWING LIVER TRANSPLANTATION: INITIALLY BRAIN EDEMA, AT LONG-TERM A DEGENERATIVE PROCESSGarcia-Martinez, R. / Alonso, J. / Rovira, A. / Cordoba, J. et al. | 2009
- S175
-
466 NATREMIA AND CHILD-TURCOTTE-PUGH (CTP) SCORE MAY IMPROVE THE SELECTION OF CANDIDATES FOR LIVER TRANSPLANTATION (LT) WITH LOW MODEL FOR END-STAGE LIVER DISEASE SCORE (MELD)Gitto, S. / Biselli, M. / Gramenzi, A. / Vitale, G. / Lorenzini, S. / Di Donato, R. / Brodosi, L. / Morelli, M. C. / Grazi, G. L. / Pinna, A. D. et al. | 2009
- S176
-
469 LONG-TERM ANALYSIS OF DROPOUT TIMES AND POST-TRANSPLANT SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA DOWNSTAGED BY TRANSARTERIAL CHEMOTHERAPYJang, J. W. / You, C. R. / Kim, C. W. / Bae, S. H. / Yoon, S. K. / Han, J. Y. / Yang, J. M. / Lee, C. D. / Lee, Y. S. / Choi, J. Y. et al. | 2009
- S177
-
472 LONG-TERM PROGNOSIS FOR TRANSPLANT-FREE SURVIVORS OF PARACETAMOL-INDUCED ACUTE LIVER FAILUREJepsen, P. / Schmidt, L. E. / Larsen, F. S. / Vilstrup, H. et al. | 2009
- S178
-
475 ANALYSIS OF PROGNOSTIC FACTORS IN MARS TREATED PATIENTSKantola, T. P. / Koivusalo, A. M. / Parmanen, S. / Hockerstedt, K. / Isoniemi, H. et al. | 2009
- S181
-
483 ETIOLOGY, OUTCOME AND APPLICABILITY OF KINGS COLLEGE PROGNOSTIC CRITERIA IN HYPERACUTE, FULMINANT AND SUBACUTE HEPATIC FAILURE IN PEDIATRIC PATIENTS IN INDIAMohan, N. / Biradar, V. / Karkra, S. / Gupta, D. / Sachdev, A. et al. | 2009
- S182
-
486 NOVEL CLASSIFICATION OF ACUTE LIVER FAILURE THROUGH CLUSTERING ANALYSIS USING A SELF- ORGANIZING MAP: USEFULNESS IN PREDICTION OF THE PROGNOSISNakayama, N. / Inao, M. / Nagoshi, S. / Fujiwara, K. / Kawamura, Y. / Mochida, S. et al. | 2009
- S183
-
489 ANTIVIRAL TREATMENT IMPROVES SURVIVAL OF PATIENTS WITH CHOLESTATIC FIBROSING HEPATITIS AFTER LIVER TRANSPLANTATION FOR HEPATITIS CRobaeys, G. / Cassiman, D. / Monbaliu, D. / Aerts, R. / Pirenne, J. / Nevens, F. et al. | 2009
- S188
-
505 RAPAMYCIN PREVENTS PROLIFERATION OF DAMAGES HEPATOCYTES DURING CHRONIC LIVER INJURY AND THEREBY LIVER TUMOR DEVELOPMENTBuitrago-Molina, L. E. / Lamle, J. / Marhenke, S. / Schungel, S. / Kossatz, U. / Breuhahn, K. / Manns, M. P. / Malek, N. / Vogel, A. et al. | 2009
- S189
-
508 EPIGENETIC METHYLATIONS AND EXPRESSIONS OF CASPASE 8 AND SURVIVIN IN HEPATOCELLULAR CARCINOMACho, S. / Cho, S. B. / Lee, W. S. / Joo, Y. E. / Kim, H. S. / Lee, J. H. / Rew, J. S. / Choi, S. K. et al. | 2009
- S190
-
511 THE NOVEL PAN-DEACETYLASE INHIBITOR PANOBINOSTAT INDUCES ALTERNATIVE PATHWAYS OF APOPTOSIS IN HEPATOCELLULAR CARCINOMA MODELSDi Fazio, P. / Schneider-Stock, R. / Wissniowski, T. / Gahr, S. / Neureiter, D. / Ocker, M. et al. | 2009
- S193
-
519 FORCED ACTIVATION OF BETA-CATENIN-REGULATED TRANSCRIPTION PREDISPOSES TELOMERASE- IMMORTALIZED HUMAN FETAL HEPATOCYTES TO ACQUIRE CANCER CELL CHARACTERISTICS: A MODEL FOR MULTI-STEP HEPATOCARCINOGENESISHeim, D. / Parplys, A. C. / Lohse, A. W. / Brummendorf, T. H. / Wege, H. et al. | 2009
- S194
-
523 ANTICANCER EFFECT OF LOW-DOSE METRONOMIC CHEMOTHERAPY IN A RAT MODEL OF HEPATOCELLULAR CARCINOMAJang, J. W. / Park, S. T. / Kim, G. D. / Kuh, H. J. / Bae, S. H. et al. | 2009
- S195
-
526 MAGNETIC FINE NEEDLES AND IRON OXIDE PARTICLES IN AN ALTERNATING MAGNETIC FIELD FOR HEPATOMA TREATMENTZuchini, J. R. / Huang, C. H. / Huang, S. C. / Shih, Y. H. / Tsai, H. W. / Hwang, S. J. / Huang, C. F. / Lee, G. B. / Lin, X. Z. et al. | 2009
- S196
-
529 FGL2 PROTHROMBINASE CONTRIBUTES TO TUMOR HYPERCOAGULABILITY VIA IL-2 AND IFN-gSu, K. / Chen, F. / Yan, W. M. / Zeng, Q. L. / Xu, L. / Xi, D. / Pi, B. / Luo, X. P. / Ning, Q. et al. | 2009
- S197
-
532 TRANSCRIPTOME ANALYSIS OF QUERCETIN EFFECT IN HEPATOCELLULAR CANCER CELLSNotas, G. / Nifli, A. P. / Kampa, M. / Pelekanou, V. / Vercauteren, J. / Castanas, E. et al. | 2009
- S198
-
535 THYROID HORMONE RECEPTOR LIGANDS INDUCE REGRESSION OF RAT PRENEOPLASTIC LIVER LESIONS CAUSING THEIR REVERSION TO A DIFFERENTIATED PHENOTYPEPerra, A. / Kowalik, M. A. / Pibiri, M. / Ledda-Columbano, G. M. / Columbano, A. et al. | 2009
- S199
-
538 THE TUMOUR MICROENVIRONMENT IN CHOLANGIOCARCINOMARobson, A. / Kiparii, T. / Iredale, J. / Forbes, S. et al. | 2009
- S200
-
541 VSV VIROTHERAPY ENHANCES CHEMOTHERAPEUTIC EFFICACY OF HUMAN LIVER CANCER CELLS BY FACILITATING APOPTOSIS DUE TO PROTEASOMAL DEGRADATION OF MCL-1Schache, P. / Struver, N. / Gurlevik, E. / Manns, M. / Kuhnel, F. / Kubicka, S. et al. | 2009
- S201
-
544 CLUSTERING HCC BY MEANS OF GENETIC SIGNALING PATHWAYSStaib, F. / Krupp, M. / Maass, T. / Lee, J. S. / Galle, P. R. / Teufel, A. et al. | 2009
- S202
-
547 IMMUNOSTIMULATION BY RFA AND CPG B IS A POTENT THERAPY IN THE VX2 HEPATOMA IN RABBITSWissniowski, T. T. / Strobel, D. / Hansler, J. / Meusel, B. / Frieser, M. / Hahn, E. G. / Ocker, M. et al. | 2009
- S203
-
550 REPLICATIVE CAPACITY OF ENTECAVIR-RESISTANT HEPATITIS B VIRUS MUTANTS IN HBeAg-NEGATIVE HEPATITIS BAmini-Bavil-Olyaee, S. / Trautwein, C. / Tacke, F. et al. | 2009
- S204
-
553 HIGH EXPRESSION OF PD-1 ON CD4+ LYMPHOCYTES MAY INTERFERE WITH VIRUS CONTROL IN HEPATITIS B CHRONICALLY INFECTED CHILDREN BY CURBING ANTIGEN-SPECIFIC T HELPER 1 RESPONSESCarey, I. / Cebecauerova, D. / Bansal, S. / Subramaniam, P. / Mieli-Vergani, G. / Vergani, D. et al. | 2009
- S210
-
572 THE HOST IMMUNITY RESPONSE OF HEPATITIS B PATIENTS AFTER ADEFOVIR DIPIVOXIL (ADV) AND ENTECAVIR (ETV) THERAPYJiang, Y. F. / Gao, P. J. / Liu, J. J. / Xin, G. J. / Niu, J. Q. et al. | 2009
- S211
-
575 THE ROLE OF APOBEC AND INOS IN MEDIATING THE NON-CYTOLYTIC CONTROL OF HEPATITIS B VIRUS REPLICATIONPhillips, S. / Evans, A. / Bertoletti, A. / Riva, A. / Naoumov, N. V. / Chokshi, S. et al. | 2009
- S214
-
583 EVALUATION OF AAV-MEDIATED IFNa-GENE THERAPY EFFICACY IN HBV TRANSGENIC MICE: CONSTITUTIVE VERSUS INDUCIBLE EXPRESSIONVanrell, L. / Olague, C. / Vales, A. / Paneda, A. / Tenembaum, L. / Gonzalez-Aseguinolaza, G. et al. | 2009
- S215
-
586 METHODS FOR VIRAL POPULATION RECONSTRUCTION VIA ULTRA-DEEP PYROSEQUENCING: HEPATITIS B VIRUS CASE STUDYProsperi, M. / Bruselles, A. / Vincenti, D. / Solmone, M. C. / Abbate, I. / Rozera, G. / Ippolito, G. / Capobianchi, M. R. et al. | 2009
- S216
-
589 HUMAN BONE MARROW MESENCHYMAL STEM CELLS ARE RESISTANT TO HBV INFECTION DURING DIFFERENTIATION TOWARDS HEPATOCYTES IN VIVO AND VITROXie, C. / Gao, Z. L. / Zheng, Y. B. / Peng, L. / Zhu, H. P. et al. | 2009
- S217
-
592 THE EXPRESSION OF SOCS-1 AND IL-6 IN THE LIVER TISSUES OF HBV RELATED END-STAGE LIVER DISEASES AND ITS CLINICAL SIGNIFICANCEZhang, Y. / Zhao, Z. / Cai, Q. / Peng, X. / Chong, Y. et al. | 2009
- S219
-
597 SERUM/ERITROCYTE RIBAVIRIN X 100 RATIO AS AN INDICATOR OF SVR IN HCV GENOTYPE-1 PATIENTS OBTAINING EVRBaiocchi, L. / De Leonardis, F. / Delle Monache, M. / Nosotti, L. / Conti, L. R. / Lenci, I. / Carbone, M. / Salso, A. / Angelico, M. et al. | 2009
- S220
-
600 SHORTENED COURSE OF THERAPY FOR CHRONIC HEPATITIS C GENOTYPE 1 (G1) PATIENTS DEVELOPING RAPID VIROLOGICAL RESPONSE (RVR): META- ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS)Cervoni, J. P. / Richou, C. / Thevenot, T. / Di Martino, V. et al. | 2009
- S223
-
608 PEGINTERFERON-RIBAVIRIN TREATMENT IS SAFE AND EFFECTIVE IN HEPATITIS C PATIENTS WITH PRE-EXISTING HEART DISEASEDurante-Mangoni, E. / Iossa, D. / Pinto, D. / Utili, R. et al. | 2009
- S224
-
610 IMPACT OF ETHNICITY ON VIRAL KINETICS AND SUSTAINED VIROLOGICAL RESPONSE RATES OF GENOTYPE 4, CHRONIC HEPATITIS C PATIENTS TREATED WITH PEG-INTERFERON-A2A PLUS RIBAVIRINElefsiniotis, I. / Pavlidis, C. / Dimitropoulos, D. / Mihas, C. / Vezali, E. / Koutsounas, S. / Paraskevas, E. et al. | 2009
- S225
-
613 THE ANTIFIBROTIC PENTOXYPHILLINE/A-TOCOPHEROL ASSOCIATION DOES NOT LIMIT LIVER FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C - ANRS HC 10Fontaine, H. / Fernandes, S. / Nalpas, B. / Bedossa, P. / Grange, J. D. / Tran, A. / Guechot, J. / Candon, S. / Imbert-Bismut, F. / Pol, S. et al. | 2009
- S226
-
616 EFFECT OF RIBAVIRIN ON THE FREQUENCY OF RNASE L CLEAVAGE SITES WITHIN THE HEPATITIS C VIRAL GENOMEMihm, U. / Hofmann, W. P. / Welsch, C. / Polta, A. / Sarrazin, C. / Lengauer, T. / Zeuzem, S. / Herrmann, E. et al. | 2009
- S227
-
619 IDENTIFYING PATIENTS INFECTED WITH HCV GENOTYPE 1 WHO MAY BENEFIT FROM EXTENDED PEGINTERFERON ALFA-2A/RIBAVIRIN THERAPY BEYOND 48 WEEKSJensen, D. / Hamzeh, F. M. / Lentz, E. / Reau, N. et al. | 2009
- S229
-
625 RISK FACTORS FOR HEPATOTOXICITY OF ARV IN HIV/HCV CO-INFECTED PATIENTS WITH A 6 YEARS FOLLOW-UP AFTER A COMPLETION OF A FULL COURSE ANTI-HCV TREATMENTKrastinova, E. / Bani-Sadr, F. / Pol, S. / Cacoub, P. / Rosenthal, E. / Perronne, C. / Carrat, F. et al. | 2009
- S230
-
627 GI-5005 IMMUNOTHERAPY PLUS PEG-IFN/RIBAVIRIN VERSUS PEG-IFN/RIBAVIRIN IN GENOTYPE 1 CHRONIC HCV SUBJECTS; PRELIMINARY PHASE 2 EVR ANALYSESLawitz, E. J. / Boyer, T. D. / Everson, G. T. / Jacobson, I. M. / Lee, W. / McHutchison, J. G. / Pockros, P. J. / Shiffman, M. L. / Vierling, J. M. / Cruickshank, S. et al. | 2009
- S232
-
632 MONITORING VIROLOGIC ON TREATMENT RESPONSE TO PREDICT TREATMENT OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS C: REALTIME PCR ASSAYS AND BDNA/TMA PROVIDE THE SAME PERFORMANCESMartinot-Peignoux, M. / Khiri, H. / Leclere, L. / Marcellin, P. / Halfon, P. et al. | 2009
- S233
-
635 INSULIN RESISTANCE AND GEOGRAPHICAL ORIGIN ARE MAJOR PREDICTORS OF LIVER FIBROSIS AND RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN IN GENOTYPE 4 CHRONIC HEPATITIS C PATIENTSMoucari, R. / Ripault, M. P. / Martinot-Peignoux, M. / Castelnau, C. / Voitot, H. / El Ray, A. / Asselah, T. / Boyer, N. / Vidaud, M. / Bedossa, P. et al. | 2009
- S235
-
640 INTRAVENOUS SILIBININ AS "RESCUE TREATMENT" FOR ON TREATMENT NONRESPONDERS TO FULL DOSE OF PEGINTERFERON/RIBAVIRIN COMBINATION THERAPYRutter, K. / Beinhardt, S. / Kerschner, H. / Scherzer, T. M. / Hofer, H. / Popow-Kraupp, T. / Steindl-Munda, P. / Ferenci, P. et al. | 2009
- S238
-
648 DIFFERENCES IN ANTIVIRAL ACTIVITY AND TOLERABILITY BETWEEN PEGYLATED INTERFERON ALPHA - 2A AND - 2B IN HIV INFECTED PATIENTS WITH CHRONIC HEPATITIS CVispo, E. / Tuma, P. / Medrano, J. / Barreiro, P. / Rodriguez-Novoa, S. / Morello, J. / Labarga, P. / Martin-Carbonero, L. / Soriano, V. et al. | 2009
- S239
-
651 ROLE OF RVR AND VIRAL LOAD ON SVR IN TREATMENT OF GT3 HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFEZehnter, E. / Hueppe, D. / Kaiser, S. / Schober, A. / Schuchmann, M. / Boeker, K. / Moog, G. / Schiffelholz, W. / Pape, S. / Heyne, R. et al. | 2009
- S240
-
654 A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERYAlessandrelli, F. / Azzaroli, F. / Feletti, V. / Lisotti, A. / Buonfiglioli, F. / Montagnani, M. / Colecchia, A. / Festi, D. / Lodato, F. / Roda, E. et al. | 2009
- S241
-
657 UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTSAzzaroli, F. / Raspanti, M. E. / Alessandrelli, F. / Feletti, V. / Buonfiglioli, F. / Cecinato, P. / Montagnani, M. / Colecchia, A. / Festi, D. / Roda, E. et al. | 2009
- S242
-
660 IS SMOKING A RISK FACTOR OF MORE SEVERE DISEASE IN PRIMARY BILIARY CIRRHOSIS?Corpechot, C. / Gaouar, F. / Chretien, Y. / Chazouilleres, O. / Poupon, R. et al. | 2009
- S243
-
663 C-MET IN HEPATOCYTES IS PROTECTIVE AGAINST CHOLESTATIC LIVER INJURY AND FIBROSIS PROGRESSION VIA ANTI-APOPTOTIC PATHWAYS IN MICEGiebeler, A. / Klein, C. / Boekschoten, M. / Borowiak, M. / Birchmeier, C. / Mueller, M. / Trautwein, C. / Streetz, K. et al. | 2009
- S244
-
666 BEZAFIBRATE TREATMENT FOR PATIENTS WITH PRIMARY BILIARY CIRRHOSIS WHO HAVE AN INCOMPLETE RESPONSE TO URSODEOXYCHOLIC ACID THERAPYHazzan, R. / Tur-Kaspa, R. et al. | 2009
- S245
-
669 CARDIAC MUSCLE BIOENERGETIC ABNORMALITY IN PRIMARY BILIARY CIRRHOSIS (PBC)Hollingsworth, K. / Newton, J. / Blamire, A. / Taylor, R. / Jones, D. et al. | 2009
- S246
-
672 CHAZOUILLERES CRITERIA ARE SUPERIOR TO THE REVISED AND SIMPLIFIED AUTOIMMUNE HEPATITIS SCORES FOR DIAGNOSING THE OVERLAP SYNDROME OF PRIMARY BILIARY CIRRHOSIS AND AUTOIMMUNE HEPATITISKuiper, E. M. / Zondervan, P. E. / van Buuren, H. R. et al. | 2009
- S248
-
677 OPPOSITE EFFECTS OF BILE ACIDS AND ESTROGENS ON HEME OXYGENASE ACTIVITY: IMPLICATIONS FOR ETHINYLESTRADIOL-INDUCED CHOLESTASISMuchova, L. / Vanova, K. / Zelenka, J. / Lenicek, M. / Juklova, M. / Cerny, D. / Farghali, H. / Wong, R. J. / Vreman, H. J. / Vitek, L. et al. | 2009
- S249
-
680 INCORPORATION OF 6-BROMOHEXANOIC ACID (6BH) INTO CELLULAR PYRUVATE DEHYDROGENASE COMPLEX (PDC): FURTHER EVIDENCE FOR GENERATION OF AN AUTOIMMUNOGENIC NEOANTIGEN IN PRIMARY BILIARY CIRRHOSIS (PBC)Palmer, J. / Walden, H. / Kirby, J. / Jones, D. et al. | 2009
- S250
-
683 INEFFICIENT PRIMING OF CD4 T-CELLS BY LIVER-DERIVED ANTIGEN IN A MOUSE MODEL OF AUTOIMMUNE HEPATITISDerkow, K. / Seidel, D. / Eickmeier, I. / Wiedenmann, B. / Schott, E. et al. | 2009
- S251
-
686 ACTIVATED INVARIANT NKT CELLS RAPIDLY PRODUCE INTERLEUKIN-17 WHICH IS ANTI-INFLAMMATORY IN EXPERIMENTAL HEPATITISWondimu, Z. / Le, T. / Swain, M. et al. | 2009
- S254
-
694 MICRORNA EXPRESSION PROFILES IN LIVER TISSUES FROM RAT FED HIGH FAT/HIGH CARBOYDRATE DIET MAY HELP TO ELUCIDATE MOLECULAR PATHOGENESIS OF NON-ALCOHOLIC FATTY LIVER DISEASEAlisi, A. / Masotti, A. / Da Sacco, L. / Piemonte, F. / Devito, R. / Alterio, A. / Bruscalupi, G. / Leoni, S. / Bottazzo, G. F. / Nobili, V. et al. | 2009
- S255
-
697 PRECISE AND SIMPLE QUANTITATION OF LIVER STEATOSIS BY MRI IN AN ANIMAL MODEL AND IN PATIENTS WITH NAFLDCesbron-Metivier, E. / Jarlot, C. / Roullier, V. / Boursier, J. / Cavaro-Menard, C. / Lebigot, J. / Michalak, S. / Cales, P. / Aube, C. et al. | 2009
- S256
-
700 LIVER REGENERATION AUGMENTING PROTEIN ALR REDUCES LIPOTOXICITY AND PROFIBROGENIC GENE EXPRESSION IN VITRODayoub, R. / Hauer, B. / Schulze, N. / Dorn, C. / Buettner, R. / Hellerbrand, C. / Schlitt, H. J. / Weiss, T. et al. | 2009
- S258
-
705 GAS6 IS INVOLVED IN THE DEVELOPMENT OF STEATOHEPATITIS AND FIBROSIS IN MOUSE LIVERFourcot, A. / Chobert, M. N. / Couchie, D. / Zafrani, E. S. / Laperche, Y. / Mavier, P. / Brouillet, A. et al. | 2009
- S260
-
711 5-LIPOXYGENASE ACTIVATING PROTEIN, FLAP, SIGNALS ADIPOSE TISSUE INFLAMMATION AND STEATOGENIC POTENTIAL IN OBESITYHorrillo, R. / Gonzalez-Periz, A. / Martinez-Clemente, M. / Lopez-Parra, M. / Ferre, N. / Titos, E. / Moran-Salvador, E. / Arroyo, V. / Claria, J. et al. | 2009
- S264
-
724 A SILYBIN-PHOSPHOLIPID-VITAMIN E COMPLEX (SILIPHOS) PREVENTS OXIDATION OF UCP2 AND LIMITS MITOCHONDRIAL DYSFUNCTION DURING NON-ALCOHOLIC STEATOHEPATITISServiddio, G. / Bellanti, F. / Romano, A. D. / Tamborra, R. / Rollo, T. / Blonda, M. / Bruno, D. / Altomare, E. et al. | 2009
- S265
-
727 THE MITOCHONDRIAL GSH LEVEL IS RESPONSIBLE FOR THE EFFICIENCY AND THE PROTECTIVE EFFECT OF SUPEROXIDE ELIMINATIONvon Montfort, C. / Matias, N. / Garcia-Ruiz, C. / Fernandez-Checa, J. C. et al. | 2009
- S266
-
730 PROTEOMICS BIOMARKERS PREDICTING HISTOLOGIC NON-ALCOHOLIC STEATOHEAPTITIS AND FIBROSISYounossi, Z. / Baranova, A. / Stepanova, M. / Calvert, V. S. / Afendy, A. / Goodman, Z. / Liotta, L. / Petrocoins, E. et al. | 2009
- S269
-
733 BRAIN OXIDATIVE METABOLISM IN BASAL CONDITIONS AND AFTER A MEMORY TASK IN CIRRHOTIC RATS WITH HEPATIC ENCEPHALOPATHYAller, M. A. / Mendez, M. / Mendez-Lopez, M. / Lopez, L. / Prieto, I. / Arias, J. / Arias, J. L. et al. | 2009
- S270
-
736 NRF2 EXPRESSION DOES NOT CORRELATE WITH ANTIOXIDANTS ENZYMES IN EXPERIMENTAL CHOLESTASISBueno-Topete, M. / Gonzalez-Cuevas, J. / Martinez-Rizo, A. / Marquez-Aguirre, A. L. / Armendariz-Borunda, J. et al. | 2009
- S271
-
739 CIRCULATING AND HEPATIC ENDOCANNABINOIDS AND ENDOCANNABINOID-RELATED MOLECULES IN PATIENTS WITH LIVER CIRRHOSISCaraceni, P. / Viola, A. / Domenicali, M. / Piscitelli, F. / Petrosino, S. / Giannone, F. / Berzigotti, A. / Zoli, M. / Cescon, M. / Grazi, G. et al. | 2009
- S272
-
742 SYMPATHETIC NERVE REGRESSION AS A POSSIBLE FACTOR CONTRIBUTING TO SUPERIOR MESENTERIC ARTERY VASODILATION IN EXPERIMENTAL PORTAL HYPERTENSIONColl, M. / Martell, M. / Raurell, I. / Bosch, J. / Genesca, J. et al. | 2009
- S273
-
745 BENEFICIAL EFFECT OF N-ACETYLCYSTEINE AND GLUTATHIONE ON AMMONIA-INDUCED GLUTAMATE ACCUMULATION IN ASTROCYTE CELL CULTUREDonnini, D. / Domenis, L. / De Silvestri, D. / Cappello, D. / Dibenedetto, A. / Carnelutti, A. / Sechi, L. / Soardo, G. et al. | 2009
- S277
-
756 INTERLEUKIN 6 AS A PROGNOSTIC FACTOR IN HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS C VIRUS CO-INFECTED PATIENTS WITH DESCOMPENSATED CIRRHOSISArjona, M. M. / Brun, F. / Marquez, M. / Rodriguez-Ramos, C. / Terron, A. / Vergara, A. / Fernandez-Gutierrez, C. / Giron-Gonzalez, J. A. et al. | 2009
- S279
-
761 PERIPHERAL AND SPLANCHNIC INDOLE AND OXINDOLE LEVELS IN CIRRHOTIC PATIENTS: A STUDY ON THE PATHOPHYSIOLOGY OF HEPATIC ENCEPHALOPATHYRidola, L. / Mannaioni, G. / Angeloni, S. / Merli, M. / Carla, V. / Salvatori, F. / Moroni, F. / Riggio, O. et al. | 2009
- S284
-
776 CIRRHOTIC THROMBOCYTOPENIA IS A MULTIFACTORIAL CONDITION: EVIDENCE OF REDUCED PLATELET PRODUCTION AND INCRESED PLATELET DESTRUCTIONPradella, P. / Zorat, F. / Uxa, L. / Comar, C. / Turchetto, S. / Bonetto, S. / Pozzato, G. et al. | 2009
- S288
-
788 INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC): TO TACE OR NOT TO TACE?Farinati, F. / Giacomin, A. / Tartaro, P. / Vanin, V. / Sergio, A. / Burra, P. / Cillo, U. / Di Nolfo, M. A. / Del Poggio, P. / Benvegnu, L. et al. | 2009
- S289
-
791 INTERLEUKIN-6, GENDER AND RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH END-STAGE LIVER DISEASEFumolo, E. / Fornasiere, E. / Bitetto, D. / Fontanini, E. / Cussigh, A. / Bragagnini, W. / Falleti, E. / Fabris, C. / Minisini, R. / Toniutto, P. et al. | 2009
- S290
-
794 PROSPECTIVE STUDY OF DYSPLASTIC NODULES IN CIRRHOSIS: CORRELATION WITH CT VASCULAR PATTERN, HISTOLOGY AND DEVELOPMENT OF HEPATOCELLULAR CARCINOMAIavarone, M. / Sangiovanni, A. / Ronchi, G. / Forzenigo, L. V. / Aghemo, A. / Lampertico, P. / Colombo, M. et al. | 2009
- S291
-
797 TISSUE MICROARRAY EVALUATION OF GLYPICAN-3, MAGE-1 AND AFP EXPRESSION PATTERNS IN HEPATOCELLULAR CARCINOMA AND THE CLINICAL IMPLICATIONSKim, S. H. / Shin, E. / Lee, K. / Zhang, M. / Park, S. Y. / Jang, J. J. et al. | 2009
- S292
-
800 EXPRESSION PATTERN AND PROGNOSTIC IMPLICATION OF HEPATIC PROGENITOR CELL MARKERS IN HEPATOCELLULAR CARCINOMASLee, K. / Shin, E. / Kim, S. H. / Zhang, M. / Lee, M. J. / Jang, J. J. et al. | 2009
- S293
-
802 TAIWAN AFP-CHILD-TUMOR (TCAT) SCORE FOR HAPATOCELLULAR CARCINOMA: A NEW PROGNOSTIC SCORING SYSTEM WITH ADEQUATE GROUPING AND REASONABLE WEIGHT OF PREDICTORSLu, S. N. / Wang, J. H. / Lin, C. Y. / Yen, Y. H. / Kee, K. / Changchien, C. S. / Hu, T. H. / Lee, C. M. et al. | 2009
- S294
-
805 PERCUTANEOUS LASER ABLATION FOR PALLIATIVE TREATMENT OF NEUROENDOCRINE LIVER METASTASESNasoni, S. / Pacella, C. M. / Bizzarri, G. / Papini, E. / Rossi, Z. / Petrolati, A. et al. | 2009
- S296
-
811 COST-EFFECTIVENESS OF RECALL STRATEGIES FOR NON-INVASIVE DIAGNOSIS OF SMALL HEPATOCELLULAR CARCINOMAPiscaglia, F. / Leoni, S. / Cabibbo, G. / Imbriaco, G. / Borghi, A. / Golfieri, R. / Bolondi, L. et al. | 2009
- S297
-
814 EVALUATION OF TUMOR PERFUSION AT COMPUTED TOMOGRAPHY AS A TOOL TO DETECT THE EFFECT OF SORAFENIB TREATMENT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)Reig, M. / Rimola, J. / Forner, A. / de Lope, C. R. / Llovet, J. M. / Ayuso, C. / Bruix, J. et al. | 2009
- S298
-
817 SEMIANNUAL VERSUS ANNUAL SURVEILLANCE OF CIRRHOTIC PATIENTS FOR EARLY DIAGNOSIS OF HEPATOCELLULAR CARCINOMA: IS THERE A WINNER?Santi, V. / Trevisani, F. / Del Poggio, P. / Di Nolfo, M. A. / Benvegnu, L. / Farinati, F. / Zoli, M. / Giannini, E. G. / Borzio, F. / Caturelli, E. et al. | 2009
- S301
-
825 ADULT CIRRHOTIC LIVER EXPLANTS: DIAGNOSIS OF UNDETECTED CHOLANGIOCARCINOMAVallin, M. / Dumortier, J. / Guillaud, O. / Adham, M. / Boillot, O. / Scoazec, J. Y. et al. | 2009
- S302
-
828 A CATHETER-MOUNTED MAGNETIC RESONANCE DETECTOR COIL FOR BILIARY IMAGING: FIRST IN VITRO BILIARY IMAGESWadsworth, C. / Syms, R. / Khan, S. / Dickinson, R. / Gedroyc, W. / Thursz, M. / Ahmad, M. / Awan, S. / Caspersz, W. / Taylor-Robinson, S. et al. | 2009
- S303
-
831 HIGH DOSE VERSUS LOW DOSE HEPATIC ARTERIAL INFUSION CHEMOTHERAPY FOR INTRACTABLE, ADVANCED HEPATOCELLULAR CARCINOMA - PROSPECTIVE RANDOMIZED TRIALBae, S. H. / Woo, H. Y. / Choi, J. Y. / Yoon, S. K. / Kim, S. G. / Kim, Y. S. / Park, J. Y. / Han, K. H. / Jang, B. K. / Hwang, J. S. et al. | 2009
- S307
-
844 POLYMER LIBRARY SCREENING IDENTIFIES AN EXTRACELLULAR MATRIX THAT PROMOTES AND STABILISES HUMAN EMBRYONIC STEM CELL-DERIVED HEPATOCYTE FUNCTIONHay, D. C. / Pernagallo, S. / Diaz-Mochon, J. J. / Fletcher, J. / Black, J. / Thompson, A. / Hannoun, Z. / Newsome, P. / Forbes, S. / Ross, J. et al. | 2009
- S308
-
847 ADULT-DERIVED HUMAN LIVER MESENCHYMAL- LIKE STEM/PROGENITOR CELLS INCREASE HEPATIC METABOLIC FUNCTION AFTER IN VITRO DIFFERENTIATIONKhuu, D. N. / Najimi, M. / Calderon, P. B. / Sokal, E. M. et al. | 2009
- S309
-
850 LIVER REGENERATION AFTER COMBINED PVE AND ADMINISTRATION OF CD34+ AUTOLOGOUS CELLS: PRELIMINARY CLINICAL EXPERIENCEMaestri, M. / Quaretti, P. / Perotti, C. / Poggi, G. / Vercelli, A. / David, G. / Gaspari, A. / Maffeis, F. / Canepa, M. C. / Peloso, A. et al. | 2009
- S310
-
852 THE NF-kB SUBUNIT C-REL IS INVOLVED IN HEPATOCYTE PROLIFERATION IN CHRONIC INJURED AND REGENERATING LIVERGieling, R. G. / Elsharkawy, A. M. / Cowie, D. / Raychaudhuri, P. / Caamano, J. H. / Oakley, F. / Mann, D. A. et al. | 2009
- S312
-
857 FOUR-COMPARTMENT 3DPERFUSION BIOREACTOR CULTURE SYSTEM ENHANCES HEPATIC MATURATION ON HUMAN FETAL HEPATOCYTESRing, A. / Gerlach, J. / Peters, G. / Pazin, B. / Minervini, C. / Triolo, F. / Gridelli, B. / Miki, T. et al. | 2009
- S313
-
860 BONE MARROW DERIVED MACROPHAGE THERAPY RESULTS IN SIGNIFICANT STRUCTURAL AND FUNCTIONAL IMPROVEMENT IN A MURINE MODEL OF CHRONIC LIVER DISEASEThomas, J. / Pope, C. / Wojtacha, D. / Hartland, S. / Iredale, J. / Forbes, S. et al. | 2009
- S314
-
863 HEPATOCYTE RXRa - A KEY ELEMENT OF LIVER REGENERATIONWan, Y. J. / Yang, X. / Guo, M. et al. | 2009
- S316
-
869 CHARACTERIZATION OF HEPATITIS C VIRUS PARTICLES IN HUMAN PLASMA: ASSOCIATION WITH IMMUNOGLOBULINS G1, G3 & M AND APOLIPOPROTEINS A-I, A-II, B, C-I AND ENielsen, S. / Sheridan, D. / Bridge, S. / Felmlee, D. / Neely, D. / Toms, G. / Bassendine, M. et al. | 2009
- S318
-
875 IDENTIFICATION AND PROFILE OF POTENT AND SELECTIVE INHIBITORS OF HCV NS5A PROTEINColonno, R. / Bencsik, M. / Peng, E. / Huang, N. / Williams, J. / Zhong, M. / Huq, A. / Wobbe, R. / Fathi, R. / Li, L. et al. | 2009
- S319
-
878 HCV-RELATED MIXED CRYOGLOBULINEMIA AND BAFF PROMOTER POLYMORPHISMGiannini, C. / Gragnani, L. / Piluso, A. / Caini, P. / Petrarca, A. / Monti, M. / Laffi, G. / Zignego, A. L. et al. | 2009
- S321
-
884 INTERFERON RELATED THYROID DISEASE IN 3414 NAIVE PATIENTS WITH CHRONIC HEPATITIS CMorisco, F. / Amoruso, D. / Tartaglione, M. / De Luna, A. / Andreone, P. / Coppola, C. / Passariello, N. / Carella, C. / Scuteri, A. / Iannaccone, C. et al. | 2009
- S326
-
899 RECOMBINANT MAMMALIAN CELL DERIVED HCV VIRUS LIKE PARTICLES TO INDUCE NEUTRALISING ANTIBODY RESPONSES TO HCVJohnson, D. / Chin, R. / Earnest-Silveira, L. / Zentgraf, H. / Bock, C. T. / Chua, B. / Jackson, D. / Torresi, J. et al. | 2009
- S327
-
902 LONG-TERM EFFICACY OF NUCLEOS(T)IDE ANALOGS AND CLINICAL USEFULNESS OF HIGHLY SENSITIVE HBV-DNA QUANTIFICATION IN PREDICTING LAMIVUDINE-RESISTANT HBVAsahina, Y. / Tamaki, N. / Hirayama, I. / Yasui, Y. / Tanaka, T. / Sato, M. / Hosokawa, T. / Ueda, K. / Ikeda, H. / Tsuchiya, K. et al. | 2009
- S328
-
904 COMPARISON OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B WITH MILDLY ELEVATED ALANINE AMINOTRANSFERASE LEVELSChen, X. F. / Chen, X. P. / Huang, J. / Chen, W. L. / Chen, R. et al. | 2009
- S329
-
907 INCREASED RISK WITH COMBINATION OF TELBIVUDINE AND PEGYLATED-INTERFERON ALFA-2A IN STUDY CLDT600A2406, COMPARED TO UNCOMMON RATE WITH TELBIVUDINE MONOTHERAPY FROM THE NOVARTIS GLOBAL DATABASEGoncalves, J. / Laeufle, R. / Avila, C. et al. | 2009
- S330
-
910 A PROSPECTIVE, RANDOMIZED STUDY OF EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A VERSUS ADEFOVIR DIPIVOXIL IN TREATING LAMIVUDINE- RESISTANT HBeAg-POSITIVE CHBHou, J. / Sun, J. / Xie, Q. / Li, X. / Zhang, J. / Wang, Y. / Wang, H. / Jak, Y. L. / Chen, S. / Jia, J. et al. | 2009
- S331
-
913 EXTENDING THE TREATMENT DURATION OF PEGINTERFERON ALFA-2A THERAPY TO 72 WEEKS INCREASES THE RATE OF HBeAg SEROCONVERSION IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS BZhu, Y. Y. / Dong, J. / Chen, Y. T. / Chen, J. / Jiang, J. J. et al. | 2009
- S334
-
920 A NOVEL HEPATITIS B VIRUS MUTATION WITH RESISTANCE TO ADEFOVIR DIPIVOXIL IN PATIENTS WITH CHRONIC HEPATITIS BLiu, L. J. / Wang, J. H. / Du, S. C. / Wei, L. et al. | 2009
- S335
-
923 SAFETY AND EFFICACY OF 96 WEEKS OF TENOFOVIR DISOPROXIL FUMARATE THERAPY IN LAMIVUDINE EXPERIENCED PATIENTSManns, M. / Jeffers, L. / Dalekos, G. / Berg, T. / Trepo, C. / Roberts, S. / Prieto, M. / Rizzetto, M. / Marcellin, P. / Heathcote, E. J. et al. | 2009
- S336
-
925 SAFETY AND TOLERABILITY OF 96 WEEKS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBeAg NEGATIVE AND POSITIVE PATIENTS INFECTED WITH CHRONIC HEPATITIS B (CHB)Marcellin, P. / Heathcote, E. J. / Jacobson, I. / Mathurin, P. / Gane, E. / Buggisch, P. / Husa, P. / Krastev, Z. / Sorbel, J. / Anderson, J. et al. | 2009
- S337
-
928 EFFECTIVENESS OF TENOFOVIR DF (TDF) MONOTHERAPY IN PATIENTS WITH PRIOR EXPERIENCE TO NUCLEOSIDE/NUCLEOTIDE ANALOGUES BY DIFFERENT PATTERN OF PRE-EXISTING MUTATIONSvan Bommel, F. / deMan, R. / Reijnders, J. / Ferenci, P. / Wedemeyer, H. / Deterding, K. / Bronowiki, J. P. / Erhardt, A. / Huppe, D. / Buggisch, P. et al. | 2009
- S338
-
930 HIGH RISK OF RENAL IMPAIRMENT DURING LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY IN PATIENTS WITH LAMIVUDINE-RESISTANT CHRONIC HEPATITIS BVigano, M. / Lampertico, P. / Iavarone, M. / Tontini, G. E. / Facchetti, F. / Colombo, M. et al. | 2009
- S340
-
936 COMBINATION OF THE NS3/4A PROTEASE INHIBITOR ITMN-191 WITH THE ALLOSTERIC NS5B POLYMERASE INHIBITOR ITMN-8020 ENHANCES REPLICON CLEARANCE AND REDUCES THE EMERGENCE OF DRUG RESISTANT VARIANTSTan, H. / Wang, G. / Moy, C. / Kossen, K. / Rajagopalan, R. / Misialek, S. / Ruhrmund, D. / Hooi, L. / Snarskaya, N. / Stoycheva, A. et al. | 2009
- S341
-
939 PRECLINICAL PHARMACOKINETIC AND ADME CHARACTERIZATION OF VCH-222, A NOVEL NON-NUCLEOSIDE HCV NS5B POLYMERASE INHIBITORChauret, N. / Chagnon-Labelle, C. / Diallo, M. / Laquerre, J. / Laterreur, J. / May, S. / Ste-Marie, L. et al. | 2009
- S342
-
942 VIRAL KINETIC MODELING DURING TREATMENT WITH INTERFERON LAMBDA-1A IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTSDodds, M. G. / Hausman, D. F. / Miller, D. M. et al. | 2009
- S343
-
945 PROTEIN SILENCING OF HCV NS3 PROTEASE: A NEW SMALL MOLECULE APPROACHHagel, M. / Niu, D. / St. Martin, T. / Sheets, M. / Qiao, L. / Bernard, H. / Chaturvedi, P. / Nacht, M. / Westlin, W. / Petter, R. et al. | 2009
- S345
-
950 PK-PD MODELING OF VIRAL KINETICS WITH UPCOMING RESISTANCE SIMULATING COMBINATION THERAPY OF LONG-ACTING INTERFERONS AND STAT-C IN HCV PATIENTSKafer, A. / Zeuzem, S. / Herrmann, E. et al. | 2009
- S346
-
953 CHARACTERIZATION OF RESISTANCE MUTATIONS SELECTED IN VITRO BY THE NON-NUCLEOSIDE HCV POLYMERASE INHIBITORS ABT-333 AND ABT-072Koev, G. / Mondal, R. / Beyer, J. / Reisch, T. / Masse, S. / Kati, W. / Hutchinson, D. / Flentge, C. / Randolph, J. / Donner, P. et al. | 2009
- S347
-
956 PHARMACOKINETICS, TOLERABILITY AND EFFECT OF FOOD ON HCV POLYMERASE INHIBITOR ABT-333 FOLLOWING SINGLE ASCENDING DOSES IN HEALTHY ADULT VOLUNTEERSMenon, R. / Cohen, D. / Nada, A. / Dumas, E. O. / Chiu, Y. L. / Podsadecki, T. / Awni, W. / Bernstein, B. / Klein, C. et al. | 2009
- S348
-
959 SUBTYPE SPECIFIC RESISTANCE PROFILES AFTER SELECTION OF HCV GENOTYPE 1A OR GENOTYPE 1B REPLICONS WITH TELAPREVIR OR HCV-796McCown, M. / Rajyaguru, S. / Cammack, N. / Najera, I. et al. | 2009
- S349
-
962 PROTEIN SILENCING OF HEPATITIS C VIRUS PROTEASE WITH A SMALL MOLECULE INHIBITOR: DISCOVERY OF AVL-181Niu, D. / Hagel, M. / Bernard, H. / Qiao, L. / Nacht, M. / Petter, R. / Sheets, M. / Singh, J. / Martin, T. S. / Westlin, W. et al. | 2009
- S353
-
974 COMPARING CLINICAL UTILITY AND PREDICTION OF IN-HOSPITAL SURVIVAL OF 3 PROGNOSTIC SCORES FOR ALCOHOLIC HEPATITIS: A MEXICAN COHORTAltamirano-Gomez, J. / Zapata-Irisson, L. / Angulo, A. G. / Ortiz-Salgado, A. / Andrade, S. et al. | 2009
- S355
-
980 BIOPSY-PROVEN NASH TREATMENT WITH RIMONABANT: A CASE SERIESBarros, F. et al. | 2009
- S357
-
985 NAFLD PREVALENCE AND CARDIOVASCULAR RISK IN A POPULATION OF ADOLESCENTS IN SOUTHERN ITALYCaserta, C. A. / Pendino, G. M. / Surace, P. / Fiorillo, M. T. / Alicante, S. / Vacalebre, C. / Amato, F. / Amante, A. / Marra, M. / Gutamo, G. et al. | 2009
- S358
-
988 INCREASED CIRCULATING TNFa, IL1, and IL6, IN THE ABSENCE OF INCREASED INTESTINAL PERMEABILITY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSISde Ferro, S. M. / Salazar, M. / Machado, M. / Ramalho, F. / Cortez-Pinto, H. et al. | 2009
- S360
-
994 VISCERAL FAT AND INSULIN RESISTANCE ARE INDEPENDENTLY CORRELATED TO DEGREE OF LIVER STEATOSIS AND STAGE OF FIBROSIS IN A NON-SELECTIVE COHORT OF OBESE PATIENTSFrancque, S. / Verrijken, A. / Mertens, I. / Hubens, G. / Van Marck, E. / Pelckmans, P. / Van Gaal, L. / Michielsen, P. et al. | 2009
- S361
-
997 FIBROSIS SHOULD BE INCLUDED INTO THE NON- ALCOHOLIC STEATOHEPATITIS SCORING SYSTEM FOR BEING MORE PROGNOSTICATIVEGunsar, F. / Yilmaz, F. / Unal, N. G. / Bayrakci, B. / Karasu, Z. / Nart, D. / Ersoz, G. / Akarca, U. S. et al. | 2009
- S362
-
1000 THE CLINICAL COURSE OF ALCOHOLIC LIVER CIRRHOSIS: A DANISH POPULATION-BASED STUDYJepsen, P. / Vilstrup, H. / Andersen, P. K. / Ott, P. / Sorensen, H. T. et al. | 2009
- S363
-
1003 VISCERAL ADIPOSE TISSUE AREA AS A STRONG AND INDEPENDENT RISK FACTOR OF ELEVATED LIVER ENZYMEKim, D. / Kim, Y. J. / Yang, J. I. / Yoon, J. H. / Cho, S. H. / Sung, M. W. / Lee, H. S. et al. | 2009
- S364
-
1006 SERUM LEVELS OF CHEMERIN AND VASPIN IN NONALCOHOLIC FATTY LIVER DISEASEKukla, M. / wirska-Korczala, K. / Hartleb, M. / Waluga, M. / Chwist, A. / Kajor, M. / Ciupinska-Kajor, M. / Berdowska, A. / Wozniak-Grygiel, E. / Buldak, R. et al. | 2009
- S365
-
1009 QUANTITATION OF STEATOSIS BY MAGNETIC RESONANCE IMAGING (MRI) AND SPECTROSCOPY (MRS) IN LIVER DISEASE: EFFECT OF HEPATIC FIBROSISMcpherson, S. / Cowin, G. / ORourke, P. / Volp, A. / Horsfall, L. / Burke, L. / Jonsson, J. / Clouston, A. / Fawcett, J. / Galloway, G. et al. | 2009
- S366
-
1012 POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASENemtsova, V. / Semyatichko, E. / Kolesnikova, O. et al. | 2009
- S367
-
1015 DYSMETABOLIC HEPATIC IRON OVERLOAD SYNDROME: ANALYSIS OF HEPCIDIN RESPONSE TO ACUTE ORAL IRON AND CHRONIC IRON OVERLOADPaolini, V. / Trombini, P. / Pelucchi, S. / Mariani, R. / Salvioni, A. / Pozzi, M. / Nemeth, E. / Ganz, T. / Piperno, A. et al. | 2009
- S368
-
1018 CANNABINOID RECEPTOR 1 EXPRESSION CORRELATES WITH ALCOHOL-INDUCED LIVER FIBROSIS: ROLE OF ACETALDEHYDEPatsenker, E. / Millonig, G. / Mueller, S. / Seitz, H. K. / Stickel, F. et al. | 2009
- S369
-
1021 SCREENING FOR LIVER ADVANCED FIBROSIS USING NON-INVASIVE BIOMARKER FIBROTEST IN GENERAL POPULATIONPoynard, T. / Lebray, P. / Ingiliz, P. / Varaud, A. / Varsat, B. / Ngo, Y. / Nohra, P. / Munteanu, M. / Morra, R. / Messous, D. et al. | 2009
- S370
-
1024 COMPARISON OF MR SPECTROSCOPY WITH MORPHOMETRIC ASSESSMENT OF LIVER BIOPSIES IN THE QUANTIFICATION FAT FRACTION IN PATIENTS WITH NAFLDRoldan-Valadez, E. / Rios, C. / Favila, R. / Martinez-Lopez, M. / Uribe, M. / Mendez-Sanchez, N. et al. | 2009
- S371
-
1027 THE EFFECT OF DIETARY INTERVENTION ON THE LONG-TERM CLINICAL OUTCOME OF NON-ALCOHOLIC FATTY LIVER DISEASEIdilman, R. / Seval, G. / Cinar, K. / Mizrak, D. / Bozkus, Y. / Arslan, M. / Bektas, M. / Erden, E. / Ozden, A. et al. | 2009
- S372
-
1030 ACCURACY OF CLINICAL SCORING SYSTEMS FOR FATTY LIVER AND ADVANCED LIVER FIBROSIS IN AN UNSELECTED OVERWEIGHT AND OBESE POPULATIONVerrijken, A. / Francque, S. / Mertens, I. / Michielsen, P. / Van Gaal, L. et al. | 2009
- S373
-
1033 PREVALENCE AND RISK FACTORS OF LIVER FIBROSIS ASSOCIATED WITH METHOTREXATE IN AN ASIAN PSORIATIC POPULATIONYeo, C. M. / Yang, W. L. / Vu, C. / Earnest, A. et al. | 2009
- S374
-
1036 INFLUENCE OF HEPATIC STEATOSIS ON THE APOB/A1 RATIO IN MALE PATIENTS WITH PREDIABETESYun, J. / Cho, Y. / Park, J. / Kim, H. / Park, D. / Sohn, C. / Jeon, W. / Kim, B. et al. | 2009
- S382
-
1052 ANTIVIRAL ACTIVITY OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN FOR 28 DAYS IN TREATMENT NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1Jacobson, I. / Pockros, P. / Lalezari, J. / Lawitz, E. / Rodriguez-Torres, M. / DeJesus, E. / Haas, F. / Martorell, C. / Pruitt, R. / Durham, K. et al. | 2009
- S383
-
1054 SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BI 207127, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS CLarrey, D. / Benhamou, Y. / Lohse, A. W. / Trepo, C. / Moelleken, C. / Bronowicki, J. P. / Arasteh, K. / Bourliere, M. / Heim, M. / Enriquez, J. et al. | 2009
- S385
-
1059 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HCV GENOTYPE 1: WEEK 28 INTERIM ANALYSISShiffman, M. / Ahmed, A. / Jacobson, I. / Pruitt, R. / Keeffe, E. et al. | 2009
- S387
-
Author Index| 2009
- v
-
Contents| 2009
- XXII
-
Subject Index| 2009
-
Editorial Board| 2009
-
8 POTENT HCV PROTEASE INHIBITORS WITH THE POTENTIAL FOR ONCE-DAILY DOSING AND BROAD GENOTYPE COVERAGEJiang, L. J. / Gai, Y. / Middleton, T. / Kurtz, K. / Lu, L. / Liu, S. / Phan, T. / Luo, X. / Poon, T. / Brasher, B. et al. | 2009
-
20 ENTECAVIR MAINTAINS A HIGH GENETIC BARRIER TO HBV RESISTANCE THROUGH 6 YEARS IN NAIVE PATIENTSTenney, D. J. / Pokornowski, K. A. / Rose, R. E. / Baldick, C. J. / Eggers, B. J. / Fang, J. / Wichroski, M. J. / Diva, U. A. / Xu, D. / Wilber, R. B. et al. | 2009
-
49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIALBruix, J. / Poynard, T. / Colombo, M. / Schiff, E. / Reichen, J. / Burak, K. / Heathcote, E. J. / Berg, T. / Poo-Ramirez, J. L. / Mello, C. B. et al. | 2009
-
62 FIBROLAMELLAR CARCINOMAS DEMONSTRATE A SPECIFIC GENETIC AND TRANSCRIPTOMIC PATTERN AMONG THE HEPATOCELLULAR CARCICOMASZucman-Rossi, J. / Couchy, G. / Imbeaud, S. / Rebouissou, S. / Balabaud, C. / Bioulac-Sage, P. / Laurent-Puig, P. et al. | 2009
-
74 THE GALLBLADDER DYSFUNCTIONS AND CONTRIBUTES TO IMPAIRED BILE SALT HOMEOSTASIS IN CYSTIC FIBROSISDebray, D. / Rainteau, D. / Lerondel, S. / Rey, C. / Humbert, L. / Barbu, V. / Wolf, C. / Cottart, C. H. / Housset, C. et al. | 2009
-
96 PERFORMANCES OF FIBROSCAN FOR DIAGNOSIS OF SIGNIFICANT FIBROSIS AND CIRRHOSIS. A PROSPECTIVE STUDY OF 1993 PATIENTS WITH CHRONIC VIRAL HEPATITISDegos, F. / Perez, P. / Roche, B. / Mahmoudi, A. / Asselineau, J. / Voitot, H. / Bedossa, P. / Fibrostic, L. G. et al. | 2009
-
216 BLEEDING IN PATIENTS WITH BUDD-CHIARI SYNDROME (BCS)Rautou, P. E. / Douarin, L. / Denninger, M. H. / Escolano, S. / Lebrec, D. / Moreau, R. / Vidaud, M. / Itzykson, R. / Moucari, R. / Bezeaud, A. et al. | 2009
-
113 MODULATION OF DEMETHYLATION AND ANTITUMOR POTENTIAL OF ZEBULARINE IN LIVER CANCERAndersen, J. B. / Raggi, C. / Marquardt, J. U. / Conner, E. A. / Lee, Y. H. / Factor, V. M. / Thorgeirsson, S. S. et al. | 2009
-
132 IMPROVEMENT OF HEPATIC INJURY AND STEATOSIS BY THE BILE ACID-PHOSPHOLIPID CONJUGATE UR- SODEOXYCHOLYL LYSOPHOSPHATIDYLETHANOLAMIDE IN A HIGH-FAT INDUCED DIETARY MODEL OF NONALCOHOLIC FATTY LIVER DISEASEPathil, A. / Warth, A. / Chamulitrat, W. / Stremmel, W. et al. | 2009
-
229 GLUTEN/CASEIN-FREE DIET AND LIVER ENCEPHALOPATYSturniolo, L. / Balzola, F. / Ottobrelli, A. / Torrani, M. / Martini, S. / Morello, E. / Smedile, A. / Leotta, D. / Orru, C. / Marchet, A. et al. | 2009
-
452 LIVER DYSFUNCTION IN DENGUE FEVERChhina, R. / Goyal, O. / Chhina, D. / Goyal, P. / Berry, A. / Mehta, V. / Kumar, R. et al. | 2009
-
190 CHANGES IN THE ETIOLOGIC AND ANTIBIOTIC RESISTANCE PROFILES OF BACTERIA CAUSING SPONTANEOUS PERITONITIS IN EGYPTIAN PATIENTS WITH LIVER CIRRHOSISGhali, A. / Fam, N. / Klena, J. / Saleh, A. et al. | 2009
-
191 UPPER GASTROINTESTINAL BLEEDING IN CIRRHOSIS: WHAT HAS CHANGED DURING THE LAST 20 YEARS?Deltenre, P. / De Maeght, S. / Ghilain, J. M. / Maisin, J. M. / Moulart, M. / Delaunoit, T. / Verset, D. / Yeung, C. / Schapira, M. / Henrion, J. et al. | 2009
-
196 PREDICTION OF CARDIAC DYSFUNCTION IN CIRRHOTIC PATIENTS USING STANDARD ECHOCARDIOGRAPHY AND COLOUR DOPPLER MYOCARDIAL IMAGINGIrnius, A. / Grabauskiene, V. / Liakina, V. / Brasiskiene, S. / Jaseviciute, A. / Valantinas, J. et al. | 2009
-
202 CIRRHOSIS IS A MAJOR PROGNOSTIC FACTOR OF SURVIVAL DIALYZED PATIENTS: THE NEPHRONORD NETWORK STUDYCastel, H. / Bellati, S. / Hazzan, M. / Noel, C. / Dharancy, S. / Wartel, F. / Louvet, A. / Canva, V. / Deltenre, P. / Nady, M. E. et al. | 2009
-
210 EFFECTS OF ALBUMIN ADMINISTRATION IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS OTHER THAN SPONTANEOUS BACTERIAL PERITONITIS. A RANDOMIZED, CONTROLLED STUDYNazar, A. / Guevara, M. / Terra, C. / Martin-Llahi, M. / Baccaro, M. E. / Pavesi, M. / Marinelli, M. / Urtasun, E. / Arroyo, V. / Gines, P. et al. | 2009
-
214 PREGNANCY IN WOMEN WITH PORTAL VEIN CAVERNOMA (PVC): MATERNAL AND FOETAL MANAGEMENT AND OUTCOMEPlessier, A. / Rautou, P. E. / Ducarme, G. / Thabut, D. / Labadi, H. / Mathurin, P. / Mazoyer, E. / Ozenne, V. / Condat, B. / Bernuau, J. et al. | 2009
-
225 PRO-COAGULANT BLOOD PRODUCT USAGE IN LIVER DISEASE PATIENTSShah, N. / Xavier, E. / Caldwell, S. et al. | 2009
-
EASL Special Conference on NAFLD/NASH and Related Metabolic Disease| 2009
-
226 ACUTE AND 14-DAYS HEPATIC VENOUS PRESSURE GRADIENT RESPONSE TO CARVEDILOL AND NEBIVOLOL IN PATIENTS WITH LIVER CIRRHOSIS. A PILOT STUDYSilkauskaite, V. / Pranculis, A. / Kupcinskas, J. / Petrenkiene, V. / Kupcinskas, L. et al. | 2009
-
235 LONG-TERM FOLLOW-UP OF PATIENTS WITH HISTOLOGICAL RESPONSE TO CHRONIC HEPATITIS B TREATMENTWong, V. / Wong, G. / Chim, A. / Choi, P. / Sung, J. / Chan, H. et al. | 2009
-
252 TUMOR NECROSIS FACTOR-ALPHA ACUTELY UP-REGULATES UREA SYNTHESIS IN VIVO IN RATS - A HEPATIC ELEMENT OF INFLAMMATORY CATABOLISMThomsen, K. L. / Nielsen, S. S. / Aagaard, N. K. / Gronbaek, H. / Flyvbjerg, A. / Vilstrup, H. et al. | 2009
-
257 ESTROGEN RECEPTOR IS INVOLVED IN THE IMPAIRMENT OF BILE SALT SECRETION INDUCED BY ESTRADIOL-17b-GLUCURONIDE IN ISOLATED RAT HEPATOCYTE COUPLETSBarosso, I. / Zucchetti, A. / Taborda, D. / Pozzi, E. S. / Crocenzi, F. et al. | 2009
-
261 FARNESOID X RECEPTOR-MEDIATED REGULATION OF THE HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A3 AND MODULATION BY URSODEOXYCHOLIC ACIDErichsen, T. J. / Aehlen, A. / Ehmer, U. / Lankisch, T. O. / Manns, M. P. / Strassburg, C. P. et al. | 2009
-
275 ADAM10, ADAM17 AND MMP2 ACTIVITIES IN HEPATIC STELLATE CELLS ARE INVOLVED IN CX3CL1 PROCESSING AND CONTRIBUTE TO CHRONIC LIVER INJURYBourd-Boittin, K. / Basset, L. / Bonnier, D. / LHelgoualch, A. / Samson, M. / Theret, N. et al. | 2009
-
279 BONE MORPHOGENETIC PROTEIN (BMP)-9: A NEW MEMBER OF THE TGF-b SUPERFAMILY WHICH IS SECRETED BY ACTIVATED HEPATIC STELLATE CELLSBreitkopf, K. / Muller, A. / Ciuclan, L. / Wiercinska, E. / Dijke, P. T. / Dooley, S. et al. | 2009
-
288 A NEW FUNCTIONAL ROLE FOR NUCLEAR MARCKS DURING CELL CYCLE IN HUMAN HEPATIC STELLATE CELLSRombouts, K. / Lottini, B. / Mello, T. / Liotta, F. / Caligiuri, A. / Marra, F. / Pinzani, M. et al. | 2009
-
291 THE HEPATIC IMMUNE MODULATION OF ASTHMA- MOUSE MODEL AND POTENTIAL ROLE OF LIVER IN RESPIRATORY DISEASEHorani, A. / Doron, S. / Kerem, E. / Shoseyov, D. / Safadi, R. et al. | 2009
-
294 FATTY ACID AMIDE HYDROLASE BUT NOT MONOACYL GLYCEROL LIPASE IS A CRITICAL INHIBITOR OF ENDOCANNABINOID-INDUCED CELL DEATH IN HEPATIC CELL POPULATIONSSiegmund, S. V. / Wojtalla, A. / Herweck, F. / Singer, M. V. et al. | 2009
-
308 MDA-7/IL-24 INDUCES APOPTOSIS OF HEPATOMA CARCINOMA CELLS BY THE ENDOPLASMIC RETICULUM STRESS IN VIVO AND IN VITROFeng, Y. et al. | 2009
-
324 THE EXPRESSION OF TBK1S IN HCV-INFECTED PATIENTSHan, M. / Li, W. / Luo, X. / Ning, Q. et al. | 2009
-
322 SERUM HYALURONIC ACID AS A USEFULR MARKER FOR PREDICTION OF THE DEGREE OF FIBROSIS IN HPATITIS BGeramizadeh, B. / Behbahani, B. / Kaboli, R. / Rahsaz, M. et al. | 2009
-
326 CYCLOPHILINS ARE ESSENTIAL HOST FACTORS FOR HCV REPLICATION: THE REQUIRED LEVEL VARIES WITH HCV CLONEInoue, K. / Watanabe, T. / Yoshiba, M. / Kohara, M. et al. | 2009
-
344 PRECLINICAL PROFILES OF IDX136 AND IDX316, TWO NOVEL MACROCYCLIC HCV PROTEASE INHIBITORSLallos, L. B. / Bilello, J. P. / Soubasakos, M. A. / Gillum, J. / Colla, M. L. / Liuzzi, M. / Carville, J. M. / Seifer, M. / Good, S. S. / Larsson, M. et al. | 2009
-
350 CLINICAL FACTORS PREDICTING ADVANCED LIVER FIBROSIS IN HEPATITIS B E ANTIGEN POSITIVE CHRONIC HEPATITIS BChan, H. L. / Wong, G. L. / Choi, P. C. / Chan, A. W. / Chim, A. M. / Yiu, K. K. / Chan, H. Y. / Wong, V. W. et al. | 2009
-
362 VALIDATION AND COMPARISON OF INDEXES FOR DETECTING COMPENSATED CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS B: A PROSPECTIVE STUDYChen, Y. P. / Hou, J. L. et al. | 2009
-
982 ANTIOXIDANT SUPPLEMENTS FOR LIVER DISEASEBjelakovic, G. / Gluud, L. L. / Nikolova, D. / Bjelakovic, M. / Gluud, C. et al. | 2009
-
385 ASSOCIATION BETWEEN HBV REPLICATION AND SERUM ALT CHANGES IS NOT DEPENDENT ON HBV GENOTYPE AND MUTANTSYang, H. I. / Iloeje, U. H. / Su, J. / Jen, C. L. / You, S. L. / Chen, C. J. et al. | 2009
-
398 HUMORAL NEUTRALIZING RESPONSE TO HCV DURING HIV COINFECTION AND LIVER TRANSPLANTATIONMaurin, G. / Roque-Afonso, A. M. / Vaghefu, P. / Gigou, M. / Duclos-Vallee, J. C. / Cosset, F. L. / Samuel, D. / Lavillette, D. / Feray, C. et al. | 2009
-
402 IMPACT OF HEPATITIS C VIRUS INFECTION ON LIVER- RELATED MORTALITY IN A LARGE COMMUNITY-BASED COHORT OF INNER CITY RESIDENTSGrebely, J. / Raffa, J. / Lai, C. / Krajden, M. / Fischer, B. / Kerr, T. / Dore, G. / Tyndall, M. et al. | 2009
-
417 EFFECT OF ANTIVIRAL THERAPY ON THE CIRCULATING LEVELS OF CYTOKERATIN-18 FRAGMENTS IN CHRONIC HEPATITIS CSgier, C. / Negro, F. / Male, P. J. / Moradpour, D. / Malinverni, R. / Heim, M. / Cerny, A. / Mullhaupt, B. / Gerlach, T. / Dufour, J. F. et al. | 2009
-
437 THE LIVER STEATOSIS IN PRE-PUBERAL OBESE CHILDREN IS NOT RELATED TO THE RESISTANCE TO INSULINExtremera, A. R. / Gallego, A. C. / Salmeron-Ruiz, A. / Casado, J. / Leon, J. / Fernandez, J. M. / Garofano, M. / Ocete, E. / Gila, A. / Sanjuan, L. et al. | 2009
-
474 THE ROLE OF MYOCARDIAL PERFUSION IMAGING (MPI) IN THE ASSESSMENT OF CARDIOVASCULAR RISK IN PATIENTS REFERRED WITH END-STAGE LIVER FAILURE FOR LIVER TRANSPLANTATIONKandiah, K. / Steeds, R. / Thorburn, D. et al. | 2009
-
487 CONVERSION FROM TACROLIMUS TWICE DAILY TO A ONCE-DAILY FORMULATION IN STABLE LIVER TRANSPLANT RECIPIENTS IS STRAIGHT FORWARD AND WELL TOLERATEDPaczek, L. / Boillot, O. / Wolf, P. et al. | 2009
-
503 MOLECULAR MECHANISMS INVOLVED IN HEPATOCARCINOMA CELLS RESISTANCE TO HYPOXIA: ROLE OF HIF-1 AND OF CARBONIC ANHYDRASE IXAlchera, E. / Dal Ponte, C. / Imarisio, C. / Tacchini, L. / Albano, E. / Carini, R. et al. | 2009